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The Role of Astrocyte and Purinergic Signaling in RTN Chemoreception 
Ian Christopher Wenker, PhD 
University of Connecticut, 2014 
Body of Abstract 
Central chemoreception is the mechanism by which the brain regulates breathing in response to changes 
in tissue pH/CO2. It is particularly important during sleep and its disruption has been associated with 
certain pathologies, including central sleep apnea and central congenital hypoventilation syndrome. A 
region of the brainstem called the retrotrapezoid nucleus (RTN) is thought to be an important site of 
central chemoreception.  
 
Recent evidence suggests that RTN chemoreception involves two mechanisms. The first appears to be H
+
-
mediated activation of neurons via inhibition of pH-sensitive potassium channels. More recently, a second 
sensing mechanism has been identified; paracrine release of ATP in the RTN region that acts on P2 
receptors. It has been postulated that astrocytes in the region release ATP, as they have been found to 
release ATP in other brain regions in response to various stimuli. However, the mechanisms by which 
astrocytes sense CO2 and/or pH are not known.  
  
Astrocytes in many brain regions are known to express Kir4.1 and/or Kir4.1-Kir5.1 potassium channels, 
which are highly pH sensitive. In addition, Kir4.1-Kir5.1 is expressed in the RTN. I hypothesize that RTN 
astrocyte sense CO2/H
+
 by inhibition of Kir4.1-Kir5.1 channels, which results in membrane 
depolarization. I also hypothesize that ATP released via connexin hemichannels in response to CO2/H
+
 
acts on P2-receptors on RTN neurons to increase neuronal action potential firing, and that this purinergic 
mechanism of chemoreception is restricted to the ventral surface, affecting primarily RTN neurons. The 
evidence described in this thesis supports four main conclusions; (1) Kir4.1/Kir5.1 channels, and the  
 ii 
 
Ian Christopher Wenker – University of Connecticut, 2014 
sodium bicarbonate cotratransporter, are the mechanism of RTN astrocyte chemosensitivity, (2) CO2-
driven purinergic signaling in the RTN is required for complete chemosensation in vivo and in vitro, (3) 
CO2-evoked ATP release is dependent on connexin hemichannels and (4) these purinergic mechanisms 
are specific to the RTN.  
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Chapter 1 Introduction 
Breathing is a physiological phenomenon that begins at birth and continues, relatively uninterrupted, until 
the end of life. For terrestrial animals, like humans, breathing occurs by moving air in and out of the 
lungs. The much needed oxygen (O2) diffuses into the blood via the pulmonary epithelial cells, and the 
waste product, carbon dioxide (CO2), likewise diffuses out.  
The drive to breathe must adjust to metabolic demand, with increases occurring during activities like 
exercise or holding one’s breath. This drive to breathe is even present during periods of relaxation or 
sleep, as is evident by our continuous respiratory activity. Conversely, disruption of the drive to breathe is 
thought to be a cause of death for people with certain pathologies, including epilepsy and stroke (Davis, 
Billings et al. 2013, Richerson, Buchanan 2011). In other cases compromised respiratory drive does not 
lead to death, but severely impacts quality of life. Such is the case in central congenital hypoventilation 
syndrome and the more common sleep apnea (Shea 1997, Dempsey, Smith et al. 2012).  
Central chemoreception is the homeostatic process by which the central nervous system senses CO2 in 
order to adequately maintain O2/CO2 levels and is a major component of respiratory drive. Although the 
study of central chemoreception dates back at least half a century, it’s cellular and molecular mechanism 
remains incompletely understood. Better understanding of these mechanisms could lead to new therapies 
to improve the quality of life for people afflicted with the aforementioned diseases. 
In addition, I would like to point out another important reason for the study of central chemoreception, 
breathing and autonomic behaviors in general. We are in the advent of modern neuroscience.  Today 
the neuroscience community is, more than ever, discussing the best ways to understand how the brain 
functions at every level. The new funding mechanisms the B.R.A.I.N. initiative in the United States and 
the Human Brain Project in the European Union, that essentially wants to create the human brain in silico, 
we are dreaming bigger than ever before. I have no doubt that the advances in the 21
st
 century will be 
astounding. However, we are still just beginning this quest. Compared to other organ systems very little is 
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known about the human brain. I propose that the study of basic physiological processes, like breathing, is 
an excellent place to begin to fully understand the brain’s function. The respiratory control system of the 
pons and medulla contains many of the hallmark characteristics of neural circuits; including gain control, 
conditioning, spontaneous and oscillatory components, neurmodulation and plasticity.  Furthermore, 
whereas other brain phenomena like anxiety, learning and memory, or compassion can be difficult to 
measure; respiratory output is easily measured and quantified, meaning greater certainty in results. In 
summary, while self-awareness and memory are exciting brain functions in need of study, let us not forget 
that homeostatic behaviors, like breathing, offer a chance to study the complexity of neural circuits, with 
more quantitative behavioral readouts. 
 
  
 
  
 3 
 
Chapter 2 Background and Literature Review 
CENTRAL RESPIRATORY CHEMORECEPTION 
Ventilation (also referred to herein as respiration or breathing) is the process an organism goes through to 
achieve adequate gas exchange. For animals the main function of ventilation is to absorb the molecular 
substrate for cellular respiration (i.e. O2) and release the byproduct (i.e. CO2). In the vast majority of 
mammals this is called “breathing” and is accomplished through the epithelium of the lungs. Air is moved 
into the lungs via negative pressure produced by contraction of the diaphragm muscle, and expelled 
passively when the diaphragm relaxes. Thus breathing requires alternating periods of diaphragm 
contraction and relaxation, and this continues, relatively uninterrupted, from birth until death.  
Unlike the heart, the lungs have no intrinsic pacemaker cells. The rhythm of diaphragm contraction is 
controlled from the central nervous system. It is commonly accepted that the mammalian respiratory 
pattern generator (rCPG) is located in the Prebotzinger complex of the ventrolateral medulla (Smith, 
Ellenberger et al. 1991). This nucleus contains inspiratory and pre-inspiratory neurons that project, 
polysynaptically via premotor neurons, to respiratory motor neurons. Phrenic motor neurons receive 
indirect Prebotzinger input, causing them to oscillate between periods of high activity and quiescence. 
Thus their synaptic connections to the diaphragm translate the activity of the rCPG into physical 
ventilatory motor activity that we call breathing.  
Respiratory rhythm is labile; increasing or decreasing depending on the metabolic demand. There are 
many homeostatic mechanisms that exist to match ventilation to metabolic demand. In the lungs there are 
mechano-, and irritant-, receptors that respond to lung stretch and irritants, respectively, and feedback via 
the brainstem to alter the respiratory rhythm (Pisarri, Jonzon et al. 1990). In the peripheral vasculature 
there are specialized organs (i.e. the aortic and carotid bodies) that sense changes in blood gases and also 
feedback to the brainstem to adjust the respiratory rhythm (O'Regan, Majcherczyk 1982). Finally, the 
respiratory centers in the brainstem receive input from higher brain centers, including the pons, 
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hypothalamus and cortex which drive breathing, and are thought to coordinate breathing changes needed 
for subconscious activities like the fear response and higher order processes like talking or singing.  
Respiratory chemosensation (hereafter referred to as simply “chemoreception”), the sensation and 
regulation of CO2/O2 levels in the body, is a major homeostatic mechanism of respiration. Disruption of 
chemoreception is thought to result in a number of breathing disorders, including central congenital 
hypoventilation syndrome (CCHS) and central sleep apnea (Weese-Mayer, Berry-Kravis et al. 2003, 
Collop 2009). Initially it was thought that the cellular components of chemoreception resided solely in the 
central nervous system (O'Regan, Majcherczyk 1982). It was subsequently found that the carotid and 
aortic bodies (now known as peripheral chemoreceptors), were capable of mediated respiratory responses 
to altered O2/CO2 levels (Heymans, Bouckaert 1930).  However, it was also observed that CO2 
chemoreception persisted even in the absence of functional carotid and aortic bodies (O'Regan, 
Majcherczyk 1982). The phenomenon of central CO2 chemoreception was later confirmed in the 1950’s 
when Leusen and colleagues used the ventricle perfusion technique to selectively reduce pH in the central 
nervous system, and observed increased ventilation (Leusen 1954). Thus it is understood that there are 
both central and peripheral chemoreceptors, the former being the focus of this thesis.   
Probably because of anatomical distinction, carotid and aortic bodies were identified as peripheral 
chemoreceptors in the early part of the 20
th
 century, which won Corneille Heymans the Nobel Prize in 
1938. On the other hand, the identity of central chemoreceptors was, and to a certain extent remains, 
elusive (Guyenet, Bayliss et al. 2009, Nattie, Li 2008). In the 1960’s Loeschcke and colleagues began to 
search for central chemoreceptors in the ventral medulla. They found that acidic solution applied to 
certain areas of the ventral lateral medulla (VLM) increased ventilation (Mitchell, Loeschcke et al. 1963, 
Loeschcke 1982). These data led to the hypothesis that central chemoreceptor cells resided in particular 
regions of the VLM.  
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By the late 1980’s the practice of brain slice electrophysiology to study neuroscience phenomena was in 
full swing, and the field of chemoreception was no exception. Finding brain regions that appeared to 
contribute to chemoreception was now not enough, and the new search was for chemoreceptor neurons. 
One of the first regions found to contain chemosensitive neurons was the nucleus of the solitary tract 
(NTS). The NTS is located in the dorsal medulla, opposite from chemosensitive regions (i.e. the VLM) 
identified decades before. In 1989, Millhorn and colleagues identified neurons in the commissural NTS 
(cNTS) that varied their action potential firing frequency in response to changes in CO2/H
+
 (Dean, 
Lawing et al. 1989). Most CO2-sensitive neurons increased action potential firing when exposed to 
elevated CO2 in the Ringers solution. It was also found that the CO2-sensitivity was not dependent on 
synaptic input, indicating this was an intrinsic response of the neuron (Dean, Bayliss et al. 1990). To this 
day the neuronal cell type and CO2 sensing mechanism in the NTS have eluded researchers.  
The next region of the medulla found to house chemosensitive neurons was that of the medullary and 
midbrain raphe. The medullary raphe is the main grouping of serotonergic neurons in the hindbrain. In 
1995 George Richerson observed CO2/H
+
-sensitive neurons in the medullary raphe, and identified them 
as serotonergic (Wang, Tiwari et al. 2001, Richerson 1995). Later, those of the midbrain were found to be 
CO2-sensitive as well (Severson, Wang et al. 2003). In addition, the mechanism of CO2 sensing was for 
the midbrain raphe chemosensitive neurons was found to be pH-sensitive TASK3 (twik-related acid-
sensitive potassium channels isoform 3 or K2P9.1), although the ablation of TASK3 had no effect on 
whole animal CO2 chemosensitivity (Mulkey, Talley et al. 2007), suggesting that although raphe neurons 
are chemosensitive, they are not major contributors to respiratory chemoreception. More recent studies, 
however, have provided evidence for a medullary serotonergic raphe neuronal role in central 
chemoreception. Dual use of Cre and Flpe receombinase systems have allowed for specific expression of 
DREADD receptors in rostral medullary raphe neurons (Armbruster, Li et al. 2007). When exposed to the 
exogenous ligand clozapine-N-oxide (CNO), DREADD (Designer Receptors Exclusively Activated by 
Designer Drugs) receptors hyperpolarize the cell membrane, thus silencing neuronal firing of action 
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potentials. Using this paradigm, the authors observed reduced CO2 chemoreception in vivo when the 
rostral medullary serotonergic raphe neurons were inhibited (Ray, Corcoran et al. 2011). 
In 2004 chemosensitive neurons were identified in a region that roughly corresponded to those identified 
by Loeschcke and colleagues in 1960’s, as evident in the editorial “Back to the future: carbon dioxide 
cheomoreceptors in the mammalian brain” (Mitchell 2004). Mulkey and colleagues identified 
chemosensitive neurons in the rostral VLM, more specifically in a region of the brain called the 
retrotrapezoid nucleus, or RTN (Mulkey, Stornetta et al. 2004). The RTN was identified years before, in 
both cats and rats, as a region with major inputs into major respiratory centers of the medulla (Smith, 
Morrison et al. 1989, Pearce, Stornetta et al. 1989). In the study by Mulkey in 2004, and following work, 
the authors found that a subset of neurons in the RTN show increased action potential firing during 
elevated CO2/H
+
, and this is not due to synaptic, carotid body or respiratory CPG input (Mulkey, Stornetta 
et al. 2004). The chemosensitive RTN neurons are glutamatergic, project to major respiratory regions and 
express the transcription factor Phox2b  (Mulkey, Stornetta et al. 2004, Stornetta, Moreira et al. 2006). 
Phox2b is a transcription fact that, when mutated in humans and mice, results in a near complete loss of 
chemoreception (Weese-Mayer, Berry-Kravis et al. 2003, Amiel, Dubreuil et al. 2009). In addition to 
dysfunctional chemoreception, mutations of Phox2b in mice resulted in the absence of chemoreceptor 
RTN neurons (Amiel, Dubreuil et al. 2009). More evidence of a role for RTN neurons in central 
chemoreception include; specific activation of Phox2b RTN neurons with channelrhodpsin2 results in 
cardio and ventilatory responses that are similar to those during hypercapnia, and when Phox2b RTN 
neurons are ablated using selective toxins decreased chemoreception is observed (Takakura, Moreira et al. 
2008, Marina, Abdala et al. 2010, Abbott, Stornetta et al. 2009). 
As apparent from above, there is range of evidence for a number of medullary regions and cell types (i.e. 
cNTS, medullary Raphe and RTN) to be involved in central chemoreception. The description here does 
not detail the work of Nattie and colleagues, who, using microdialysis of CO2/H
+
 into the medulla have 
determined a number regions (including those mentioned above) that appear to contribute to 
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chemoreception (Nattie, Li 2008). These observations have led to the “distributed theory” of central 
chemoreception, in which there are multiple neuronal groups that are sensitive to CO2/H
+
 and activate the 
respiratory system. The reason for multiple neuronal types with the same function is not clear, although 
the common response is “redundancy” (Nattie, Li 2008). Redundancy is the concept that important 
functions, like respiratory control, will have backups in case one becomes nonfunctional. This certainly 
appeals to logic. Yet, destruction of even a small number of these neurons in the Prebotzinger complex, 
the group of neurons necessary for respiratory rhythm to be generated (Tan, Janczewski et al. 2008), 
results in a loss of respiratory motor activity (Hayes, Wang et al. 2012). Even with a system so 
susceptible to small amounts of cell death breathing continues. An alternative view could be that each 
chemosensitive neuronal population contributes to central chemoreception in its own way. For instance, 
medullary raphe chemosensitive neurons could modulate behavior of the respiratory system (e.g. they are 
serotonergic and serotonin is a common neuromodulator), RTN neurons could provide more tonic 
excitatory input to the system (e.g. they are glutamtergic) and NTS neurons may effect peripheral 
autonomic reflexes (e.g. they are located in the major visceral relay center of the medulla). In any case, 
direct evidence to indicate a single chemoreceptor site is lacking. This would require specific ablation of 
the CO2/H
+
-sensing mechanism in a particular set of cells, while preserving all other function of those 
cells. This would likely be accomplished by using transgenic approaches to eliminate CO2/H
+
-sensing 
mechanisms in specific cell populations. To begin to construct such transgenic experiments we must first 
determine the cellular identity and sensing mechanisms of particular chemoreceptors cells. As such, in 
this thesis I have focused on determining CO2/H
+
-sensing mechanisms of RTN chemoreceptor neurons 
and astrocytes. 
PURINERGIC SIGNALING 
Adenosine tri-phosphate, ATP, a purine nucleotide, is an important player in molecular biology. Most 
notably ATP is the “molecular currency” of energy transfer within a cell. Much of the study of 
biochemistry is concerned with its synthesis and metabolism. ATP is generated during glycolysis, 
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photosynthesis and cellular respiration and the energy stored in the three phosphate bonds can be used for 
many cellular functions. For instance, transmembrane pumps, such as the Na-K-ATPase, use the energy 
stored in the phosphate bonds of ATP to move molecules against their electrochemical gradient. 
Intracellular signaling pathways utilize ATP as a substrate by kinases that phosphorylate proteins and 
lipids, and by adenylate cyclase, which produces the second messenger molecule, cyclic AMP. More 
recently ATP has been found to be involved in intercellular signaling, acting in autocrine, paracrine and 
neurocrine mechanisms on membrane bound purinergic receptors (Burnstock 2007).  
Perhaps due to the fact that ATP is such an important molecule for cell metabolism it was difficult for the 
scientific community to accept that it was involved in intercellular signaling. The first observation that 
ATP can act extracellularly occurred during experiments on cardiac tissue in 1929 (Drury, Szent-Gyorgyi 
1929). Later it was found to act in the intestine and parts of the spinal cord (Buchthal, Engbaek 1947, 
Gillespie 1934). Exogenous ATP acts as an antagonist to certain anesthetics and is released from nerve 
axons (Kuperman, Okamoto et al. 1964, Kuperman, Volpert et al. 1964). In 1970 Geoffrey Burnstock 
postulated that ATP is used for specific intercellular signaling (Burnstock, Campbell et al. 1970). He 
discovered nerves in the autonomic nervous system innervating the gut and bladder that utilized ATP as 
their neurotransmitter. Since then ATP has been described as a neurotransmitter in the autonomic, central 
and nociceptive nervous systems and is a cotransmitter in many other regions (Burnstock 2007). 
The membrane receptors whose ligands are purines and pyrimidines are commonly referred to as 
purinergic receptors.  There are at least three different families of purinergic receptors; P1 (also referred 
to as adenosine receptors), P2X and P2Y receptors. Purinergic receptors have been found to be located in 
many regions of the body and function in an equally wide array of cellular processes.  
P1 receptors are G-protein coupled receptors. There are four P1 receptor subtypes; A1, A2A, A2B and 
A3, which all respond to adenosine as their endogenous agonist. When A1 and A3 receptors are activated 
they stimulate Gs, increasing cAMP, whereas activation of A2A and A2B receptors stimulates Gi, 
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decreasing cAMP (Burnstock 2007). P1 receptor activation causes decreased heart rate, coronary 
vasodilatation and A2B, in combination with neutrin-1, is involved with axon elongation in neurons 
(Fredholm, IJzerman et al. 2011).  
P2X receptors are ionotropic with two transmembrane domains. There are seven cloned P2X subtypes; 
P2X1-7, which all respond to ATP as their endogenous agonist. P2X receptors act as cation channels and 
upon activation by ATP, allow the flow of sodium, potassium and in some cases calcium. This causes 
depolarization of the cell membrane, which in turn can open Ca
2+ 
channels (Dubyak, el-Moatassim 1993). 
P2X1-6 are all very similar in structure while P2X7 has an elongated intracellular peptide sequence on the 
carboxy end. When exposed to ATP it initially functions as the other P2X receptors, however if the ATP 
exposure is prolonged its pore enlarges and larger molecules can flow through. It is mainly expressed in 
immune and glial cells, and seems to allow the release of proinflamatory cytokines (Burnstock 2008). 
P2X receptors have been located in neurons, glia, bone, muscle, endothelium and hematopoietic cells 
(North 2002), and have functions including fast synaptic transmission (Bardoni, Goldstein et al. 1997), 
neurotransmitter release (Khakh, Henderson 1998) and pain signaling (Cockayne, Hamilton et al. 2000).  
P2Y receptors are G-coupled with seven transmembrane spanning domains. There are eight P2Y receptor 
subtypes that have been cloned; P2Y1, P2Y2, P2Y4, P2Y6 and P2Y11 through P2Y14 (Erb, Liao et al. 
2006, Burnstock 2007). P2Y receptors respond to a more varied array of endogenous agonists, including 
ATP, ADP and even uridine nucleotides UTP and UDP. The strength of response to these agonists varies 
by receptor subtype, which is sometimes used for subtype identification. For instance, if a cell exhibits a 
physiological response to ATP and UTP, but not ADP then the responsible receptor is likely either P2Y2 
or P2Y4. G-proteins utilized by P2Y receptors are Gi, Go, Gs, Gq/G11, Gi, G12 and Gi/Go (Erb, Liao et al. 
2006). Some P2Y receptor subtypes have specific G-proteins they associate with, but many can associate 
with multiple. For example, the P2Y2 receptor can activate Go, Gq/G11 and G12 (Erb, Liao et al. 2006). 
Stimulation of these G-proteins by recombinant P2Y receptors can either activate phospholipase C (PLC) 
or adenylate cyclase, causing intracellular Ca
2+
 release or changes in cAMP levels, respectively. P2Y 
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signaling is responsible for numerous physiological responses (Burnstock 2007). P2Y receptors are 
thought to play a role in the activation of ion channels, including the volume-regulated anion channel 
(Darby, Kuzmiski et al. 2003) and of N-type Ca
2+
 channels (Abbracchio, Burnstock et al. 2006). P2Y 
receptor expression has been shown to influence cell proliferation in a number of cell types (Bagchi, Liao 
et al. 2005) and is upregulated in response to tissue injury (Ahn, Camden et al. 2000, Rohatgi, Sedehizade 
et al. 2003). 
GLIAL CELLS 
Glial cells were discovered during the mid-19
th
 century, not too long after Scwhann and Schleiden 
theorized that all living matter was composed of cells in 1839 (Kimelberg 2004)  It was Rudolf Virchow 
who first coined the term neuroglia, meaning “neural-cement,” in 1856 (Ndubaku, de Bellard 2008). 
Virchow’s histochemical stains illustrated clear distinctions between neurons and glia but were unable to 
delineate between the different subtypes of glia. Using the black chrome-silver reaction Camillo Golgi 
was the first to distinguish radial glia from other glia and neurons in 1895 (Kimelberg 2004). Ramon y 
Cajal was the first to use the term “astrocyte” t describe the fibrous and protoplasmic glial subset (Somjen 
1988). In 1920, Cajal’s student del Rio Hortega was able to distinguish oligodendrondrocytes and 
microglia from the other two glial subsets (Somjen 1988).  
Glial cells have since been split into two broader classes of macroglia and microglia, the latter being the 
primary immune cell in the brain. Macroglia in the peripheral nervous system (PNS) consist of Schwann 
cells and satellite cells. Schwann cells’ main role is that of axon myelination (Ndubaku, de Bellard 2008). 
Satellite cells line the exterior portion of the PNS and regulate the exterior chemical environment 
(Topilko 2007). Macroglia in the CNS consist of three distinct types; oligodendrocytes, polydendrocytes 
and astrocytes. Similar to Schwann cells, oligodendrocytes have small somas and large end feet that are 
responsible for axon myelination (Ndubaku, de Bellard 2008). Polydendrocytes, also called NG2 glia, are 
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the major proliferative cell type in the adult brain, mostly giving rise to new oligodendrocytes 
(Nishiyama, Komitova et al. 2009).  
Astrocytes account for approximately 20-30% of brain cells in the mature CNS and are crucial for 
maintaining relative homeostasis (Hertz, Zielke 2004, Kimelberg 2004). In the microenvironment 
astrocytes mediate neurotransmitter and ionic homeostasis, synaptic formation, neuronal excitability and 
migration, detoxification and maintenance of the blood brain barrier (Markiewicz, Lukomska 2006). 
Astrocytes are thought to secrete a wide variety of neurotrophic factors, such as nerve growth factor, 
NGF, and brain-derived neurotrophic factor BDNF (Villegas, Poletta et al. 2003). Astrocytes regulate the 
extracellular space near synapses after high neuronal output by buffering potassium (Leis, Bekar et al. 
2005, Olsen, Campbell et al. 2007) as well as neurotransmitters (Hertz, Zielke 2004). 
Originally astrocytes, as well as other glial cells, were thought to simply provide neurons with structural 
support, but in more recent decades it has become clear that astrocytes also are directly involved in 
information processing. They are able to stabilize as well as modulate synaptic activity (Haydon, Blendy 
et al. 2009). Astrocytes express many neurotransmitter receptors that, when activated, initiate calcium 
signaling (Villegas, Poletta et al. 2003). These calcium waves spread between adjacent astrocytes via gap 
junctions and purinergic signaling (Inoue, Koizumi et al. 2007), which can then trigger release of ATP 
and glutamate; the main mediators of neuron-glia cross-talk (Villegas, Poletta et al. 2003). Astrocytes also 
have been found to communicate with microglia and capillaries (Inoue, Tsuda et al. 2007), making them a 
major playing or neurovascular coupling (Straub, Nelson 2007). 
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Chapter 3 Hypothesis and Specific Aims 
Central chemoreception is the mechanism by which the brain regulates respiration in response to changes 
in tissue pH/CO2. Chemosensitivity is particularly important during sleep and its disruption has been 
associated with central sleep apnea & hypoventilation syndrome (Weese-Mayer, Berry-Kravis et al. 2003, 
Collop 2009). A region of the brainstem called the retrotrapezoid nucleus (RTN) is thought to be an 
important site of central chemoreception (Mulkey, Stornetta et al. 2004).  
 
Recent evidence suggests that RTN chemoreception involves two mechanisms. The first appears to be H
+
-
mediated activation of pH-sensitive neurons, via inhibition of TASK2 channels (Wang, Benamer et al. 
2013). When TASK2 is ablated the CO2/H
+
-sensitivity of RTN neurons reduced, but not entirely ablated. 
The second sensing mechanism appears to involve paracrine release of ATP that acts on neuronal P2 
receptors (Gourine, Llaudet et al. 2005). Hypercapnia (elevated CO2/H
+
) induces ATP release at the 
medullary ventral surface and pharmacological blockade of P2 receptors, or destruction of ATP by 
apyrase, in this region blunts central chemoreception in vivo (Gourine, Llaudet et al. 2005). It is thought 
that H
+
/CO2-evoked ATP release acts on P2 receptors of pH-sensitive RTN neurons. It has been 
postulated that astrocytes in the region release ATP, as they have been found to release ATP in response 
to various stimuli in other brain regions (Straub, Nelson 2007). However, the source and mechanisms of 
this purinergic drive to breathe remains undetermined. 
 
Hypothesis. I hypothesize that RTN astrocytes sense CO2/H
+
 by inhibition of Kir4.1/Kir5.1 channels, 
which results in membrane depolarization. I also hypothesize that ATP released in response to CO2/H
+
 
acts on P2-receptors expressed by RTN neurons to increase neuronal action potential firing, and that this 
purinergic mechanism of chemoreception is restricted to the ventral surface, affecting primarily RTN 
neurons. 
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Specific Aim 1. Determine the CO2/H
+
-sensitive membrane properties of glial cells in the RTN. 
Subsequently, identify the cell type (i.e. astrocyte, microglia etc.) and sensing mechanism (i.e. channel). 
This was accomplished via patch-clamp recordings from glial cells, and post-hoc immunohistochemical 
analysis of glial cell markers. 
 
Specific Aim 2. Determine the role of P2 receptors on RTN neuronal chemosensitivity, in vivo and in 
vitro. For in vitro studies, this was accomplished by making loose patch recordings from rat brain slices 
of RTN neurons and measuring their response to CO2/H
+
 under control conditions and in the presence of 
P2 antagonists. Also, I will use neuronal recordings as an assay to determine the mechanism of release by 
using pharmacology to block gap junction hemichannels and inhibitors of vesicle fusion. In vivo, the 
effect of P2 antagonist injection into the RTN on cardiorespiratory parameters was studied in anesthetized 
adult rats. 
 
Specific Aim 3. Determine the regional specificity of puringergic signaling contribution to central 
chemoreception in vivo and in vitro. This was accomplished using the same methods as described in Aim 
2. In vitro, loose patch recordings were made from CO2-sensitive neurons in the caudal NTS (cNTS) and 
medullary raphe pallidus (RPa). These cells were assayed to see if they functionally express P2 receptors, 
and if these receptors contribute to their chemosensitivity. Similarly, in vivo, cardiorespiratory responses 
to hypercapnia in anesthetized rats were tested under control conditions and during P2 receptor blockade 
in the cNTS and RPa. In addition, ATP injection into these regions was performed to test for functional 
P2 receptor expression in vivo. 
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Chapter 4 Astrocyte of the Retrotrapezoid Nucleus Sense H+ by Inhibition of a Kir4.1-Kir5.1-like 
Current and May Contribute to Chemoreception by a Purinergic Mechanism 
 
INTRODUCTION 
A region of the caudal brain stem called the retrotrapezoid nucleus (RTN) contains a population of 
neurons that are highly pH sensitive in vivo and in vitro, are glutamatergic, and project to respiratory 
centers to influence breathing (Abbott, Stornetta et al. 2009, Mulkey, Stornetta et al. 2004). The 
mechanism by which these RTN chemoreceptors sense pH involves inhibition of an unidentified voltage-
independent K
+
 conductance (Mulkey, Stornetta et al. 2004). The absence of an identified molecular pH 
sensor in RTN neurons has raised the possibility that multiple mechanisms contribute to chemoreception 
(Filosa, Putnam 2003) and, despite the apparent intrinsic pH sensitivity of RTN neurons, it remains 
possible that local paracrine mechanisms contribute to chemoreception by the RTN.  
 
There is increasing evidence that adenosine 5′-triphosphate (ATP), released by astrocytes, is an important 
mediator of chemoreception. Previous in vivo studies showed that hypercapnia evoked the discrete release 
of ATP within the RTN (Gourine, Llaudet et al. 2005). Further, application of ATP into the RTN 
stimulated respiratory output, whereas application of an ATP receptor antagonist (pyridoxal-phosphate-6-
azophenyl-2′,4′-disulfonate [PPADS]) to the RTN lowered CO2 respiratory responses (Gourine, Llaudet 
et al. 2005). Recently, it was shown that RTN astrocytes respond to bath acidification with Ca
2+
-
dependent, exocytosis-mediated, ATP release (Gourine, Kasymov et al. 2010). In addition, 
photostimulation of RTN astrocytes expressing channelrhodopsin-2 (ChR2) resulted in a robust increase 
in breathing (Gourine, Kasymov et al. 2010), strongly suggesting that astrocytes contribute to respiratory 
drive. This study also provided evidence suggesting that ATP release from astrocytes is a requisite signal 
for neuronal pH sensitivity (Gourine, Kasymov et al. 2010). At the cellular level, we have shown that 
purinergic signaling can activate pH-sensitive RTN neurons via P2Y receptors (Mulkey, Mistry et al. 
2006). However, we also found that the pH sensitivity of RTN neurons in HCO3
−
-free HEPES-buffered 
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media was retained when ATP receptors were blocked with PPADS (100 μM) (Mulkey, Mistry et al. 
2006), indicating that ATP is not a requisite component of neuronal pH sensitivity. These results suggest 
that RTN neurons are intrinsically pH sensitive but that CO2-evoked release of ATP can modulate the 
activity of pH-sensitive neurons and contribute to the integrated output of the RTN (i.e., respiratory drive) 
during hypercapnia. 
 
The goals of this study were to 1) confirm that RTN astrocytes are pH sensitive, 2) identify mechanism(s) 
by which these cells sense changes in pH, and 3) determine the extent to which they contribute to 
chemoreception. To make these determinations, we used the brain slice preparation and a combination of 
patch-clamp electrophysiology and immunohistochemistry to identity pH-sensitive glia and to determine 
the mechanism by which they sense changes in pH. To explore the possibility that pH-sensitive RTN 
astrocytes stimulate activity of pH-sensitive neurons by a purinergic mechanism, we determined the effect 
of fluorocitrate-mediated astrocyte activation on pH-sensitive neurons. We found that pH-sensitive RTN 
glia are protoplasmic astrocytes that sense H
+
, in part, by inhibition of a Kir4.1–Kir5.1-like current and 
may contribute to respiratory drive by increasing activity of pH-sensitive RTN neurons by a purinergic-
dependent mechanism.  
 
METHODS 
Brain stem slices 
Slices containing the RTN were prepared as previously described (Jiang, Xu et al. 2001, Matthias, 
Kirchhoff et al. 2003). Briefly, neonatal rats (7–12 days postnatal) were decapitated under 
ketamine/xylazine anesthesia and transverse brain stem slices (300 μm) were cut using a microslicer 
(DSK 1500E; Dosaka, Kyoto, Japan) in ice-cold substituted Ringer solution containing (in mM): 260 
sucrose, 3 KCl, 5 MgCl2, 1 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, 10 glucose, and 1 kynurenic acid. Slices 
were incubated for about 30 min at 37°C and subsequently at room temperature in normal Ringer solution 
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(in mM): 130 NaCl, 3 KCl, 2 MgCl2, 2 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, and 10 glucose. Both 
substituted and normal Ringer solutions were bubbled with 95% O2-5% CO2.  
 
Electrophysiology 
Individual slices were transferred to a recording chamber mounted on a fixed-stage microscope (Zeiss 
Axioskop FS) and perfused continuously (∼2 ml min−1) with a bath solution composed of (in mM): 140 
NaCl, 3 KCl, 2 MgCl2, 2 CaCl2, 10 N-2-hydroxyethylpiperazin-N′-2-ethanesulfonic acid (HEPES), 10 
glucose; pH was adjusted between 6.9 and 7.5 by addition of HCl or NaOH. To test pH sensitivity of 
RTN astrocytes in bicarbonate-based buffer slices were perfused with normal Ringer solution bubbled 
with 95% O2-5% CO2 (bath pH = 7.45). The pH of the bicarbonate-based bath solution was decreased to a 
pH of about 6.8 by bubbling with 15% CO2 as previously described (Filosa, Putnam 2003).  
 
All recordings were made with an Axopatch 200B patch-clamp amplifier, digitized with a Digidata 
1322A A/D converter, and recorded using pCLAMP 10.0 software (Molecular Devices). Recordings were 
obtained at room temperature with patch electrodes pulled from borosilicate glass capillaries (Warner 
Instruments) on a two-stage puller (P89; Sutter Instrument) to a DC resistance of 4–7 MΩ when filled 
with an internal solution containing the following (in mM): 120 KCH3SO3, 4 NaCl, 1 MgCl2, 0.5 CaCl2, 
10 HEPES, 10 EGTA, 3 Mg-ATP, 0.2% biocytin, and 0.3 GTP-Tris (pH 7.2); electrode tips were coated 
with Sylgard 184 (Dow Corning). Voltage-clamp recordings from glia were made at a holding potential of 
−80 mV and in the presence of tetrodotoxin (TTX, 0.1 μM) to block neuronal activity. Holding current, 
conductance, and current–voltage (I–V) relationships were determined using voltage steps between −40 
and −150 mV. Neuronal firing rate histograms were generated by integrating action potential discharge in 
10-s bins and plotted using Spike 5.0 software. It is important to recognize that in a whole cell recording 
circuit, recording cells with a low membrane resistance (e.g., passive astrocytes) in series with a large 
access resistance (Ra) can result in voltage-clamping error. In our experiments, we limited Ra to about 10 
MΩ by preparing tissue from young animals; capacitance and Ra compensation (70%) were used to 
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minimize voltage errors as previously described (Matthias, Kirchhoff et al. 2003). Recordings were 
discarded if Ra varied >10% during an experiment. A liquid junction potential of 10 mV was corrected 
off-line. Data were reported as means ± SE and were analyzed by the paired t-test or ANOVA and 
Dunnett's multiple comparison test when appropriate (P < 0.05).  
 
Immunohistochemistry 
Recorded slices were fixed in 4% paraformaldehyde in 0.1 M sodium phosphate buffer (pH 7.4) for 2 h at 
4°C and rinsed in phosphate-buffered saline (PBS). Slices were blocked and permeabilized in PBS 
containing 5% normal goat serum and 0.4% Triton X-100 for 1 h at room temperature. Biocytin was 
detected by incubation in Alexa 488–conjugated strepavidin (1:1,000; Invitrogen) for 1 h at room 
temperature. After three PBS washes, the slices were incubated in primary antibodies overnight at 4°C, 
washed, and then incubated in secondary antibodies for 1 h at room temperature. Slices were washed in 
PBS and mounted in Vectashield. Images were collected on a Leica TCS SP2 confocal microscope 
equipped with 488-, 543-, and 633-nm laser lines and tunable emission wavelength detection. For each 
labeled slice, a biocytin-positive cell was identified and confocal z-stacks were collected sequentially for 
the other two channels to detect glial antigens. A cell was scored as immunopositive if the 
immunoreactivity for one or more glial markers was detected in the biocytin-positive cell body and 
processes. To determine background fluorescence of the tissue and nonspecific binding of secondary 
antibodies, we tested secondary antibodies without preincubation in primary antibody. These methods 
have been optimized for 300-μm slices sequentially detecting biocytin and glial antigens.  
 
Drugs 
Tetrodotoxin was purchased from Alomone Labs (Bethlehem, Israel); all other chemicals were obtained 
from Sigma (St. Louis, MO). Fluorocitrate was prepared as previously described (Holleran, Babbie et al. 
2001). Briefly, the Ba
2+
 salt of fluorocitric acid was dissolved in 0.1 M HCl and the Ba
2+
 was precipitated 
by the addition of Na2SO4 (0.1 M). This solution was centrifuged at 800 g for 10 min and the supernatant 
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removed and diluted in HEPES-buffered medium to a final concentration of 100 μM (pH 7.3 by addition 
of 1 N NaOH). To confirm that Ba
2+
 was adequately removed during the preparation of fluorocitrate, we 
also prepared a solution of equal Ba
2+
 concentration minus fluorocitric acid and subjected it to the same 
precipitation protocol described earlier.  
 
RESULTS 
This study consists of two series of experiments. First, I made whole cell recordings to identify pH-
sensitive RTN glia and to characterize the mechanism by which they sense pH. I initially identified glia 
by their small size, hyperpolarized membrane potential, and inability to form action potentials during 
depolarizing current injection; cellular identity was later confirmed using immunohistochemistry. In a 
second series of experiments, I made loose-patch recordings from pH-sensitive RTN neurons to determine 
the effects of fluorocitrate-mediated astrocyte activation on baseline activity and pH sensitivity of RTN 
neurons and to test effects of P2-receptor antagonists on neuronal CO2 sensitivity.  
 
Astrocyte chemoreceptors 
Previous sharp electrode recordings showed that ≤44% of RTN glia respond to extracellular acidification 
with membrane depolarization (Fukuda, Honda et al. 1978). In the whole cell configuration and HCO3
−
-
free HEPES-buffered solution we found that roughly 20% of RTN glia were pH sensitive; cells were 
considered pH sensitive if they showed >10 mV/pH unit change in membrane potential, ≥40 pA change in 
holding current, or 35% change in conductance when cycling bath pH between 7.5 and 6.9. Based on 
these criteria, we found a bimodal distribution of pH-sensitive and -insensitive glial cells (Fig. 1F). In 
current-clamp, pH-sensitive RTN glia have a resting membrane potential of −80 ± 1 mV (n = 8) and 
respond to acidification from pH 7.5 to 6.9, with a depolarization of 8.8 ± 1.4 mV (n = 8) that occurs 
within about 6 min (Fig. 1, A and B). We hypothesize that the slow kinetics of pH-sensitive astrocytes is 
reflective of their modulatory role and likely helps maintain stable chemoreceptor output despite fast   
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Figure 1  
Characteristics of pH-sensitive retrotrapezoid nucleus (RTN) glia in HEPES buffer. A: traces of 
membrane potential and bath pH show that acidification from 7.3 to 6.9 causes a reversible 
depolarization. B: summary of H
+
 effects on membrane potential of pH-sensitive astrocytes (n = 5, *P < 
0.05). C: traces of holding current (top) and conductance (bottom) during changes in bath pH show that 
alkalization increases and acidification decreases outward current and conductance. D and E: current 
responses to voltage steps from −80 mV to between −40 and −150 mV (E) and corresponding current–
voltage (I–V) relationships under alkaline and acidic conditions (D). To isolate the pH-sensitive I–V (♣), 
we subtract I–V relationships obtained at pH 6.9 (▴) from those recorded at pH 7.5 (■). F: percentage 
change in conductance during acidification from pH 7.5 to 6.9 observed from all glial cells recorded in 
the RTN. G: average I–V relationship (n = 5) of pH-sensitive current reverses near the equilibrium 
potential for K
+
 (EK
+
, arrow). 
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breath-by-breath oscillations in tissue pH (Millhorn, Eldridge et al. 1984). In contrast, pH-insensitive glia 
have a resting membrane potential of −74 ± 3 mV (n = 12) that did not vary over the same pH range. 
After recording, cells were filled with biocytin to characterize morphology and immunohistochemical 
phenotype. We found that 18 of 20 (90%) pH-sensitive glia were immunoreactive for aldehyde 
dehydrogenase 1L1 (Aldh1L1) (Fig. 2, A–C), an antigen that is expressed by protoplasmic astrocytes 
(Cahoy, Emery et al. 2008). In addition, pH-sensitive glia typically extended numerous fine radial 
projections near blood vessels (Fig. 2D) and to be dye-coupled (evidence of gap junctions) to other 
astrocytes (Fig. 2, A–C). These results support recent evidence that GFAP-expressing cells near the 
ventral surface are CO2 sensitive (Gourine, Kasymov et al. 2010) and indicate that pH-sensitive glia are 
protoplasmic astrocytes.  
 
To further characterize electrical properties of pH-sensitive astrocytes and establish their role as intrinsic 
pH sensors, we made voltage-clamp recordings of whole cell currents in HEPES buffer at control pH 7.3 
and during exposure to alkaline and acidic conditions. Note that these experiments were performed in 
TTX (0.1 μM) to block neuronal activity. Under control conditions, pH-sensitive astrocytes display high 
K
+
 conductance and exhibit fairly time- and voltage-independent responses to voltage steps. These 
properties are consistent with those of passive astrocytes described in the hippocampus (Matthias, 
Kirchhoff et al. 2003, Zhou, Schools et al. 2006) and brain stem (Grass, Pawlowski et al. 2004). 
Astrocytes in the RTN respond to acidification from pH 7.5 to 6.9, with a decrease in holding current of 
91.8 ± 10 pA (n = 23) and a decrease in conductance of 6.8 ± 0.8 nS (n = 23) (Fig. 1C). This corresponds 
with a decrease in whole cell current of about 53% at +40 mV. By comparison, RTN astrocytes are more 
pH sensitive than astrocytes in a nonrespiratory region like the hippocampus; passive hippocampal 
astrocytes respond to acidification from 7.4 to 6.0 with a decrease in whole cell current at +20 mV of only 
about 28% (Zhou, Xu et al. 2009). To confirm that the pH sensitivity of RTN astrocytes is determined by 
intrinsic membrane properties, rather than intercellular current spread through gap junctions, we tested the 
effects of carbenoxolone (a nonspecific gap junction blocker) on astrocyte pH sensitivity. Carbenoxolone  
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Figure 2 
pH-sensitive RTN glia are gap junction coupled protoplasmic astrocytes. A, left: a transverse slice 
between bregma −11.6 to −11.2 mm that contains the RTN. Right: map showing relative locations of 18 
pH-sensitive RTN astrocytes (green circles correspond to the cells shown in the bottom panels). B1 and 
B2: biocytin filled pH-sensitive RTN glial cells (green, arrows) and dye-coupled cells (other green cells). 
C1 and C2: aldehyde dehydrogenase 1L1-labeled (Aldh1L1, red) astrocytes. D1 and D2: merged images 
of the same cells in B and C show double-labeling for biocytin (green) and Aldh1L1 (red); the pH-
sensitive astrocytes (arrows) and dye-coupled partners colocalize with Aldh1L1 labeling. E1 and E2: 
merged images of the same cells in B and C show double-labeling for biocytin (green) and laminin (blood 
vessels, blue). Note that pH-sensitive RTN astrocytes have cell bodies positioned near blood vessels (E1) 
and extend processes to blood vessels (truncated arrows in E2). Each image is the average projection of a 
confocal stack; around 30 images taken every 0.26 μm in the Z plane. 
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(100 μM) increased the pH-sensitive current by roughly 18% (Data not shown), suggesting that RTN 
astrocytes are intrinsically pH sensitive. Astrocytes are known to express high levels of the electrogenic 
Na
+
/HCO3
−
 cotransporter (NBC), which can generate an inward depolarizing current (i.e., HCO3
−
 efflux) 
during bath acidification (Deitmer 1991, Munsch, Deitmer 1994). To determine whether activity of the 
NBC contributes to the pH-sensitive current in RTN astrocytes, we characterized CO2/H
+
 sensitivity of 
RTN astrocytes in normal Ringer solution (26 mM HCO3
−
, 5% CO2). In current-clamp, pH-sensitive RTN 
astrocytes had a membrane potential of −82 ± 1.2 mV (n = 3), which is about 2 mV hyperpolarized to 
resting potential of astrocytes in HCO3
−
-free HEPES buffer, and responded to hypercapnia (15% CO2, 
pHo = 6.8) with a membrane depolarization of 9 ± 2.3 mV (Fig. 3, A and B). In voltage-clamp, exposure 
to 15% CO2 decreased holding current from 139.8 ± 20 to 54.9 ± 8.9 pA (n = 8), which corresponded with 
a change in holding current of 130 ± 17 pA/pH unit, whereas in HEPES buffer acidification from 7.3 to 
6.9 changed in the holding current 62.7 ± 6 pA/pH unit (Fig. 3G). In addition, the CO2/H
+
-sensitive 
current had a reversal potential of −105 mV (Fig. 3E), which is more negative than the reversal potential 
of the pH-sensitive current in HCO3
−
-free HEPES buffer, suggesting that activity of one or more HCO3
−
 
transporters contributes to pH sensitivity of RTN astrocytes. The most likely candidate is the electrogenic 
NBC, which can generate a depolarizing inward current (i.e., HCO3
−
 efflux) during bath acidification 
(Chesler 2003, Deitmer 1991). Therefore we used diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS, an 
NBC blocker) to isolate the contribution of this transporter to pH sensitivity of RTN astrocytes. At control 
pH = 7.4, exposure to DIDS (0.5 mM) decreased holding current by 41.6 ± 8 pA (n = 3) (Fig. 3C). In the 
continued presence of DIDS, exposure to 15% CO2 decreased holding current by 45.2 ± 13 pA (n = 3) 
(Fig. 3C), which corresponds with a change in holding current of 69.5 ± 20 pA/pH unit (Fig. 3G). The 
CO2/H
+
-sensitive current in DIDS reversed at −94 mV (i.e., near the equilibrium potential for K+ [EK
+
]) 
(Fig. 3, D and F), as expected for a current dominated by K
+
 conductance.  
 
The DIDS-sensitive current exhibited a reversal potential of −104 mV, which is slightly hyperpolarized to  
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Figure 3 
Characteristics of pH-sensitive RTN glia in bicarbonate buffer. A: traces of membrane potential 
shows that exposure to 15% CO2 causes a reversible membrane depolarization. B: summary of the effects 
of 15% CO2 on membrane potential pH-sensitive astrocytes (n = 3). C: trace of holding current shows that 
15% CO2 decreases outward current and conductance. Under control conditions (i.e., 5% CO2, pHo = 
7.45), exposure to diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS, 0.5 mM) also decreased holding 
current close to 100 pA. In the continued presence of DIDS, a second exposure to 15% CO2 decreased 
holding current also by about 100 pA. D and E: current responses to voltage steps from −80 mV to 
between −40 and −150 mV during 5% and 15% CO2 exposure in bicarbonate buffer alone or in the 
presence of DIDS (D) and corresponding I–V relationships of the average CO2/H
+
-sensitive current (i.e., 
difference current) (n = 3) in bicarbonate buffer alone (E) or bicarbonate buffer with DIDS (F). Note that 
under control conditions the reversal potential of the CO2/H
+
-sensitive current is hyperpolarized to EK
+
 
(arrow in E), but when activity of the electrogenic Na
+
/HCO3
−
 cotransporter (NBC) is blocked with 
DIDS, the CO2/H
+
-sensitive current reverses near EK
+
 (arrow in F). G: summary data comparing effects of 
CO2/H
+
 on holding current (at a holding potential of −80 mV) in HEPES and bicarbonate-buffered media. 
Activity of the NBC significantly increased acid-induced changes in holding current compared with 
HCO3
−
-free HEPES solution or in the presence of DIDS (*P < 0.05). 
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the predicted reversal potential for the NBC (ENBC). For example, the ENBC was calculated with the 
following equation (Newman 1991): ENBC = RT/F(n − 1) ln [Na
+
]i[HCO3
−
]i
n
/[Na
+
]o[HCO3
−
]o
n
, where n is 
the 2HCO3
−
:1Na
+
 stoichiometry and R (gas constant), T (temperature), and F (Faraday constant) have 
their usual meanings. For a temperature of 22°C, [Na
+
]o = 157 mM, [Na
+
]i = 4 mM, [HCO3
−
]o = 26 mM, 
and [HCO3
−
]i was estimated to be 22 mM using the Henderson–Hasselbalch equation as previously 
described(Gross, Hawkins et al. 2001); we calculated ENBC to be −99 mV. It is not clear why the DIDS-
sensitive current reversed about 5 mV negative to ENBC, although DIDS has been shown to have 
nonspecific effects on anion exchangers and Cl
−
 channels in glia(Munsch, Deitmer 1994), which may 
account for the discrepancy. To confirm that Cl
−
 channels do not contribute to CO2 sensitivity of RTN 
astrocytes, we tested CO2 sensitivity in low chloride (50 mM) buffer.  
 
The low Cl
−
 solution was made isoosmotic by replacing 80 mM NaCl with an equal amount of Na-
gluconate. We found the CO2/H
+
-sensitive current was not affected by chloride reduction. For example, 
there was no difference between the CO2/H
+
-induced change in holding current under control conditions 
(92.3 ± 38 pA; n = 3) and in low Cl
−
 buffer (91.3 ± 37 pA; n = 3) (not shown). Likewise, amplitude and 
reversal potential of the CO2/H
+
-sensitive current were similar in control and low Cl
−
 conditions (data not 
shown).  
 
In the absence of NBC activity (HCO3
−
-free HEPES buffer or Ringer solution with DIDS), the CO2/H
+
-
sensitive current expressed by RTN astrocytes reversed near the equilibrium potential for K
+
 (EK
+
 = −97 
mV), suggesting that one or more pH-sensitive K
+
 channels contribute to the pH sensitivity of RTN 
astrocytes. Astrocytes have been shown to express several types of pH-sensitive K
+
 channels, including 
background TASK channels and heteromeric Kir4.1–Kir5.1 channels. In particular, heteromeric Kir4.1–
Kir5.1 channels are exquisitely sensitive to pH in the physiological range (Casamassima, D'Adamo et al. 
2003, Xu, Yang et al. 2000), are preferentially expressed by astrocytes (Hibino, Fujita et al. 2004, Tang, 
Taniguchi et al. 2009), and in situ hybridization shows detectable levels of both Kir4.1 and Kir5.1 mRNA 
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in the RTN (Wu, Xu et al. 2004). Therefore we consider heteromeric Kir4.1–Kir5.1 channels the most 
likely molecular pH sensor in RTN astrocytes.  
 
Heteromeric Kir4.1–Kir5.1 channels confer pH sensitivity to RTN astrocytes 
The possible contribution of Kir channels can easily be distinguished from background K
+
 channels based 
on Ba
2+
 sensitivity (Olsen, Sontheimer 2008); most Kir channels, but not background K
+
 channels, are 
fully inhibited by micromolar concentrations of Ba
2+
 (for review of background and Kir channel 
pharmacology see (Kubo, Adelman et al. 2005, Goldstein, Bayliss et al. 2005, Patel, Honore 2001). 
Therefore to determine whether heteromeric Kir4.1–Kir5.1 channels contribute to pH sensitivity in RTN 
astrocytes, we first determine effects of Kir channel inhibition by Ba
2+
 (100 μM) on membrane potential 
and the pH-sensitive current. In current-clamp, Ba
2+
 depolarized the membrane potential by 16.7 ± 3.0 
mV (n = 4) (Fig. 4A). In voltage-clamp (at −80 mV, TTX), Ba2+ decreased outward current by 86.5 ± 5 
pA (n = 4) (Fig. 4B) and blocked the pH-sensitive current by 96.5 ± 3.5% (n = 4) (Fig. 4, B, D, and F). 
Note that if a more Ba
2+
-sensitive background channel like TWIK (Ba
2+
 half-maximal inhibitory 
concentration [IC50] = 100 μM; (Patel, Honore 2001)) or TASK-1 (Ba
2+
 IC50 = 350 μM; (Patel, Honore 
2001)) contributed to the pH-sensitive current in RTN astrocytes, we would expect that only a portion (at 
best ∼50%) of the pH-sensitive current would be blocked by 100 mM Ba2+. However, we show that this 
concentration of Ba
2+
 virtually eliminated the pH-sensitive current, suggesting that background K
+
 
channels do not confer pH sensitivity to RTN astrocytes. Inhibition of other voltage-gated K
+
 channels 
with tetraethylammonium (TEA, 10 mM) or 4-aminopyridine (4-AP, 50 μM) had no effect on the pH-
sensitive current in RTN astrocytes (Supplemental Fig. S1A). These results indicate that one or more Kir 
channels contribute to the pH-sensitive current in RTN astrocytes.  
 
To differentiate the contribution of Kir4.1–Kir5.1 channels from other Kir channels, we inhibited Kir4.1-
containing channels (i.e., homomeric and heteromeric channels) with desipramine (100 μM). At this 
concentration, desipramine inhibits channels containing Kir4.1 subunits, with minimal effects on other  
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Figure 4 
pH sensitivity of RTN glia involves heteromeric Kir4.1 channels. A1: membrane potential trace shows 
that inhibition of Kir channels mimics the effects of H
+
; Ba
2+
 (100 μM) and desipramine (des, 100 μM) 
depolarize membrane potential by about 18 and 9 mV, respectively. A2: average depolarization of RTN 
pH-sensitive astrocyte when exposed to either H
+
 (acidification from 7.3 to 6.9, n = 5), 100 μM Ba2+ (n = 
4), or 100 μM desipramine (n = 5). B: trace of holding current shows that H+ decreases outward current. 
At pH 7.3, Ba
2+
 decreases holding current and blocks effects of pH on holding current. C: trace of holding 
current from a pH-sensitive astrocyte shows desipramine decreases holding current and blocks effects of 
pH on holding current. D: average (n = 4) I–V relationship of the pH-sensitive current under control 
conditions and in the presence of 100 μM Ba2+ shows negligible pH-sensitive current in Ba2+. E: average 
(n = 4) I–V relationship of the pH-sensitive current under control conditions and in the presence of 
desipramine shows negligible pH-sensitive current in desipramine. F: average pH-sensitive current 
amplitude (at −80 mV) recorded from RTN astrocytes during acidification from pH 7.5 to 6.9, exposure 
to Ba
2+
 (n = 3), or desipramine (n = 4) (*P < 0.05). 
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pH-sensitive Kir channels (Su, Ohno et al. 2007, Tang, Taniguchi et al. 2009). Our results indicate that 
desipramine mimics effects of acidification; in current-clamp exposure to desipramine depolarized 
membrane potential by 8.4 ± 3.0 mV (n = 4) (Fig. 4A) and in voltage-clamp it decreased holding current 
by 35.0 ± 13 pA (n = 4) (Fig. 4C) and the pH-sensitive current by 72.7 ± 21.3% (n = 4) (Fig. 4, C, E, and 
F). It should be noted that desipramine is also a tricyclic antidepressant and may have nonspecific effects 
on neuronal activity. However, RTN astrocytes are not responsive to norepinephrine or serotonin (DK 
Mulkey, unpublished observations), suggesting the effects of desipramine on these cells is mediated by 
inhibition of Kir4.1-containing channels. These results suggest that heteromeric Kir4.1–Kir5.1 channels 
confer pH sensitivity to RTN astrocytes.  
 
RTN astrocytes activate pH-sensitive neurons by a purinergic mechanism 
Recent evidence suggests that a subset of RTN astrocytes contribute to the mechanism of chemoreception 
by sensing CO2/H
+
 and releasing ATP to activate pH-sensitive neurons and increase respiratory drive 
(Gourine, Kasymov et al. 2010). These results are supported by our evidence that roughly 20% of RTN 
astrocytes are intrinsically pH sensitive. To test the possibility that pH-sensitive astrocytes modulate 
activity of pH-sensitive neurons, we paralleled previous in vivo experiments by using fluorocitrate to 
selectively depolarize astrocytes (Erlichman, Li et al. 1998, Holleran, Babbie et al. 2001) while recording 
activity of pH-sensitive neurons. Fluorocitrate is a metabolic toxin that is selectively taken up by 
astrocytes, where it can initiate membrane depolarization (Erlichman, Leiter 2010), presumably by energy 
depletion and loss of cytoplasmic K
+
. At subtoxic doses, fluorocitrate has been shown to reversibly 
depolarize RTN glia and increase ventilatory sensitivity to CO2 (Erlichman, Li et al. 1998, Holleran, 
Babbie et al. 2001), by yet unknown mechanisms. We confirmed that fluorocitrate (50 μM) can reversibly 
depolarize pH-sensitive astrocytes (data not shown). We also confirmed the effects of fluorocitrate are not 
due to residual Ba
2+
 by determining that Ba
2+
 precipitation control solution, prepared in a manner similar 
to fluorocitrate, had no effect on neuronal or glial membrane potential. We found that fluorocitrate 
evoked a large and reversible neuronal activation (Fig. 5, A and B). Importantly, a second exposure to  
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Figure 5 
RTN astrocytes increase baseline activity and pH sensitivity of RTN chemoreceptors by a P2-
receptor–dependent mechanism. A: traces of pH and firing rate (Hz) from a pH-sensitive neuron shows 
a characteristic response to H
+
: increasing pH to 7.5 inhibited activity, whereas acidification to pH 6.9 
increased firing rate >2 Hz. At a control pH of 7.3, exposure to fluorocitrate (fluoro, 50 μM) evoked a 
large and reversible increase in neuronal activity. A second exposure to fluorocitrate, this time in the 
presence of a P2-receptor antagonist pyridoxal-phosphate-6-azophenyl-2′,4′-disulfonate (PPADS), 100 
μM, blocked the effects of fluorocitrate. Fluorocitrate responsiveness returned in wash. B: traces of pH 
and firing rate from a pH-sensitive RTN neuron exposed to acidic and alkaline conditions in the presence 
and absence of fluorocitrate (fluoro, 50 μM) or PPADS (100 μM). Fluorocitrate alone stimulated neuronal 
activity. In the continued presence of fluorocitrate, acidification further increased firing rate by about 1 
Hz, whereas alkalization decreased activity. Note that the effects of pH but not fluorocitrate were retained 
in the presence of PPADS. Bar graphs summarize the effects of fluorocitrate in the presence of PPADS 
(top, n = 5) and in acidic and alkaline conditions (bottom, n = 3) (*P < 0.05). 
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fluorocitrate, this time in the presence of an ATP receptor antagonist (PPADS, 100 μM), had no effect on 
neuronal activity (Fig. 5A). In addition, fluorocitrate also increased neuronal pH sensitivity; in the 
continued presence of fluorocitrate, responsiveness to acidification increased by 0.7 ± 0.2 Hz (n = 3), 
compared with acid alone (Fig. 5B). These results also confirm previous results that P2 receptors are not 
required for pH sensitivity of RTN neurons in slices incubated in HEPES buffer (Mulkey, Mistry et al. 
2006); pH sensitivity of RTN neurons was wholly retained in the presence of PPADS (Fig. 5B). It has 
been suggested that CO2 and not H
+
 per se is the stimulus required for ATP release from RTN astrocytes 
(Spyer 2009). Therefore we tested the effect of PPADS and another P2-receptor antagonist (suramin, 100 
μM) on CO2/H
+
 sensitivity in bicarbonate-buffered medium. As shown in Fig. 6, exposure to 15% CO2 
alone increased neuronal activity 2.2 ± 0.1 Hz (n = 12). After washing to 5% CO2 exposure to PPADS 
(100 μM) significantly decreased baseline activity from 0.13 ± 0.05 to 0.02 ± 0.01 Hz (n = 8). Likewise, 
suramin (100 μM) decreased baseline activity 0.50 ± 0.1 Hz to 0.3 ± 0.1 Hz (n = 4). These results suggest 
that in bicarbonate buffer (pH 7.3) RTN chemoreceptors receive tonic excitatory purinergic input. Prior to 
testing CO2/H
+
 sensitivity in PPADS or suramin, a depolarizing current (∼1 nA) was delivered to the 
neuron to approximate the control level of activity. In the continued presence of PPADS (with baseline 
activity adjusted by DC current injection to near control levels), a second exposure to 15% CO2 increased 
neuronal activity by 1.6 ± 0.1 Hz (n = 8); this response was significantly less than the CO2 response under 
control conditions (initial response or in wash) (Fig. 6A). In the presence of suramin (with baseline 
activity adjusted to near control levels), a second exposure to 15% CO2 increased neuronal activity by 1.4 
± 0.1 Hz; this response was significantly less than the CO2 response under control conditions (Fig. 6B). 
These results indicate that P2-receptor antagonists PPADS and suramin decreased CO2/H
+
 sensitivity. To 
the extent that fluorocitrate selectively affects astrocytes (Erlichman, Leiter 2010), these results suggest 
that astrocytes can release ATP and activate pH-sensitive neurons, presumably by a P2Y-dependent 
mechanism (Mulkey, Mistry et al. 2006), to increase chemoreceptor output. These results also lend 
support to the hypothesis that pH-sensitive astrocytes contribute to chemoreception by increasing activity 
of pH-sensitive neurons.   
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Figure 6 
In bicarbonate-buffered solution astrocytes contribute to chemosensitivity by a purinergic 
mechanism. A: trace of firing rate shows the response of an RTN neuron to increases in CO2 from 5 to 
15% in bicarbonate buffer alone or in the presence of PPADS. An initial exposure to 15% CO2 increased 
the firing rate about 2.8 Hz. After returning to 5% CO2, exposure to PPADS (100 μM) decreased baseline 
firing rate, suggesting that in bicarbonate buffer RTN chemoreceptors receive tonic excitatory purinergic 
input. A depolarizing current (∼1 nA) was delivered to the neuron to increase firing rate to near control 
levels. In the continued presence of PPADS (with baseline activity adjusted by DC current injection to 
near control levels), a second exposure to 15% CO2 increased the firing rate about 1.5 Hz. After washing, 
PPADS CO2 sensitivity returned to initial levels. Bar graph on the right summarizes the firing rate 
response of RTN neurons (n = 9) to 15% CO2 in control and PPADS (*P < 0.05). B: firing rate trace 
shows the response of a RTN chemoreceptor to 15% CO2 in bicarbonate-buffered solution alone and in 
the presence of suramin (100 μM). An initial exposure to 15% CO2 increased the firing rate about 2.7 Hz. 
As was observed with PPADS, exposure to suramin (100 μM) in 5% CO2 decreased baseline firing rate. 
A depolarizing current (∼1 nA) was delivered to the neuron to increase firing rate to near control levels. 
In the continued presence of suramin (with baseline activity adjusted by DC current injection to near 
control levels), a second exposure to 15% CO2 increased firing rate about 1.7 Hz. After washing, suramin 
CO2 sensitivity returned to initial levels. The asterisk designates a 5-min break. Bar graph on the right 
summarizes the firing rate response of RTN neurons (n = 5) to 15% CO2 in control and suramin (*P < 
0.05). 
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DISCUSSION 
Neuron–glia communication has emerged in recent years as a fundamental process in the brain that can be 
an important determinant of neuronal activity. However, by most accounts the activity of astrocytes is 
thought to be under the strict control of neuronal input (Fellin, Pascual et al. 2006). Here we show that 
RTN astrocytes sense H
+
 in part by inhibition of heteromeric Kir4.1–Kir5.1 channels and stimulate 
activity of RTN chemoreceptors by a P2-receptor–dependent mechanism. Our evidence also indicates that 
purinergic input is not required for RTN chemoreceptor function. These results identify the most likely 
mechanism by which RTN astrocytes sense pH and build on recent evidence that astrocytes contribute to 
respiratory drive by a purinergic mechanism (Gourine, Kasymov et al. 2010).  
 
Molecular mechanism underlying pH sensing by RTN astrocytes 
Fukuda and colleagues showed >30 years ago that the RTN contains a population of pH-sensitive 
nonspiking cells (Fukuda, Honda et al. 1978) and more recent evidence shows these pH sensors express 
the NBC (Ritucci, Erlichman et al. 2005), thus narrowing the scope of candidates to either astrocytes or 
oligodendrocytes. Our data indicate that pH-sensitive RTN glia are protoplasmic astrocytes; specifically, 
these cells have a hyperpolarized membrane potential; high K
+
 conductance; exhibit an electrically 
passive profile; and express Aldh1L1, a marker of protoplasmic astrocytes (Cahoy, Emery et al. 2008).  
 
Several pH-sensitive channels have been proposed to contribute to the mechanism of chemoreception, 
including Ca
+2
-activated K
+
 channels (KCa) (Wellner-Kienitz, Shams et al. 1998), voltage-sensitive K
+
 
channels (e.g., transient and delayed rectifying K
+
 channels)(Putnam, Filosa et al. 2004, Filosa, Putnam 
2003), background TASK channels (Bayliss, Talley et al. 2001, Mulkey, Stornetta et al. 2004), and Kir 
channels(Schultz, Czachurski et al. 2003, Zhu, Liu et al. 2000, Xu, Cui et al. 2000). All of these channels 
are expressed in various types of glial cells and conceivably contribute to the pH sensitivity of RTN 
astrocytes. Our results show that the pH-sensitive current in RTN astrocytes can be blocked with 100 μM 
Ba
2+
, which will fully block most Kir channels, with only modest effects on background K
+
 channels 
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(e.g., TASK channels) (Goldstein, Bayliss et al. 2005, Kubo, Adelman et al. 2005, Patel, Honore 2001). 
In addition, the pH-sensitive current in RTN astrocytes was not blocked by TEA (10 mM) or 4-AP (50 
μM), which can inhibit other voltage- and Ca2+-dependent K+ channels, thus narrowing the scope of 
candidate molecular sensors to one or more Kir channels.  
 
The Kir family of channels consists of 16 different channel subunits grouped into seven subfamilies 
(Kir1.x–Kir7.x) based on sequence homology (Olsen, Sontheimer 2008). All Kir channels are composed 
of four α-subunits assembled as homomeric or heteromeric channels that show varying degrees of 
rectification, single-channel conductance, and pharmacology. A common feature of most Kir channels is 
high sensitivity to low micromolar concentrations of Ba
2+
 (Kubo, Adelman et al. 2005, Mulkey, Stornetta 
et al. 2004), a property that is frequently used to differentiate contributions of Kir channels from other K
+
 
channels, including background K
+
 channels (Mulkey, Stornetta et al. 2004). Only certain Kir channels 
are pH sensitive, e.g., Kir1.1 (pK = 6.7) (Xu, Yang et al. 2000), Kir2.3 (pK = 6.8) (Putnam, Filosa et al. 
2004), homomeric Kir4.1 (pK = 6.1) (Pessia, Imbrici et al. 2001), and the heterodimeric Kir4.1–Kir5.1 
channels (pK = 7.4) (Casamassima, D'Adamo et al. 2003, Xu, Yang et al. 2000). Note that Kir5.1 subunits 
do not form functional homomeric channels, but preferentially heteromerize with Kir4.1 subunits in 
astrocytes (Casamassima, D'Adamo et al. 2003, Pessia, Tucker et al. 1996). Of all pH-sensitive Kir 
channels, only heteromeric Kir4.1–Kir5.1 channels are exquisitely sensitive to physiologically relevant 
pH changes. Further, in situ hybridization found that the RTN expresses high levels of Kir4.1 and Kir5.1 
mRNA (Wu, Xu et al. 2004). Here, we show that RTN astrocytes respond to physiologically relevant pH 
changes. The pH-sensitive current expressed by these cells appears relatively voltage independent 
between −150 and −30 mV and was almost completely blocked by micromolar concentrations of Ba2+ and 
desipramine (a blocker of Kir4.1-containing channels; (Su, Ohno et al. 2007, Tang, Taniguchi et al. 
2009)). This combination of features (i.e., inhibition by physiologically relevant changes in pH and 
micromolar concentrations of Ba
2+
 and desipramine) is most consistent with heteromeric Kir4.1–Kir5.1 
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channels. Therefore we consider heteromeric Kir4.1–Kir5.1 channels to be excellent candidate pH sensors 
of RTN astrocytes.  
 
Our results also indicate that the NBC contributes to the pH-sensitive current in RTN astrocytes. It is well 
established in various types of astrocytes that activity of the NBC generates a hyperpolarizing outward 
current (i.e., net HCO3
−
 influx) at membrane potentials depolarized to ENBC (Chesler 2003). In our 
experimental conditions we calculated the ENBC to be about −99 mV. As expected, at a holding potential 
of −80 mV in bicarbonate-buffered solution we observed a DIDS-sensitive outward current. This outward 
current will likely increase during depolarization and so potentially blunt H
+
-mediated inhibition of 
Kir4.1–Kir5.1 and the corresponding membrane potential. However, the NBC is also modulated by 
changes in extracellular pH; bath acidification can reverse Na
+
-HCO3
−
 transport to produce an inward 
depolarizing current (i.e., net HCO3
−
 efflux) (Chesler 2003, Deitmer 1991). In voltage-clamp (at a holding 
potential of −80 mV), we show that inward current produced by the NBC increased amplitude of the 
CO2/H
+
-sensitive current and caused a negative shift in its reversal potential. When activity of the NBC 
was blocked with DIDS, we observed a CO2/H
+
-sensitive current that was similar in amplitude to that of 
the pH-sensitive current in HCO3
−
-free HEPES solution and reversed near EK
+
. A contribution of the 
NBC to central chemoreception has yet to be established and considering that H
+
-induced depolarization 
and extracellular acidification have offsetting effects on directionality of Na
+
/HCO3
−
 transport by the 
NBC, further experiments are required to define potential roles of this transporter in RTN 
chemoreception.  
 
Possible role of astrocytes in central chemoreception 
There are two mechanisms by which astrocytes are thought to influence chemoreception. First, a well-
known function of astrocytes is to help regulate extracellular K
+
 by taking up extracellular K
+
 ions during 
increased neuronal activity (Olsen, Sontheimer 2008). This process effectively buffers changes in 
extracellular K
+
; however, it can also depolarize membrane potential and increase Na
+
/HCO3
−
 cotransport 
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into glia (Chesler 2003), which would enhance the CO2-induced fall in extracellular pH and potentiate 
activation of chemoreceptors. This possibility is supported by a series of in vivo experiments in which 
fluorocitrate microinjected into the RTN caused extracellular acidification followed by increased 
respiratory frequency and ventilatory sensitivity to CO2 (Erlichman, Leiter 2010, Holleran, Babbie et al. 
2001). Note that fluorocitrate is a toxin that inhibits metabolic activity; at low concentrations it has been 
shown to be selectively taken up by astrocytes but not neurons, where it initiates membrane 
depolarization (Erlichman, Leiter 2010), presumably by loss of cytoplasmic K
+
. However, it is also 
possible that the fluorocitrate-mediated effects described in these experiments resulted from the release of 
excitatory gliotransmitters acting on pH-sensitive neurons. Our data support this latter possibility. For 
example, we found that exposure to fluorocitrate activated pH-sensitive neurons under conditions in 
which the NBC is minimally active (i.e., in HEPES buffer). In addition, we were able to block effects of 
fluorocitrate with a P2-receptor antagonist. Therefore the most likely mechanism by which astrocytes 
contribute to chemoreception involves release of ATP and activation of pH-sensitive neurons. Our data 
also indicate that fluorocitrate caused an upward parallel shift in the pH sensitivity of RTN neurons, 
suggesting that fluorocitrate-mediated ATP release from RTN astrocytes contributes to chemoreception 
by increasing excitability of RTN neurons. These results are consistent with evidence in other brain 
regions that astrocytes serve as a source of excitatory purinergic drive able to rapidly modulate neural 
activity (Gordon, Iremonger et al. 2009). However, it should be noted that these experiments are limited 
by a dearth of pharmacological tools available to selectively manipulate astrocytes and the possibility that 
fluorocitrate may have nonspecific effects on other cell types, including neurons. Therefore additional 
experiments that use genetic approaches to selectively manipulate astrocytes are required to definitively 
establish a role of pH-sensitive astrocytes in chemoreception. It is important to note that our results are 
entirely consistent with a recent study that used the adenoviral system to target expression of ChR2 to 
RTN astrocytes (Gourine, Kasymov et al. 2010). This study showed that photostimulation of RTN 
astrocytes increased activity of RTN neurons and stimulated breathing by a purinergic-dependent 
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mechanism. These results are similar to the observed effects of fluorocitrate, thus adding to our 
confidence that fluorocitrate effects are mediated by astrocytes.  
 
Based on the results described earlier, it is reasonable to expect P2-receptor antagonists to decrease pH 
sensitivity of RTN neurons. However, previous experiments performed in HEPES-buffered media 
(Mulkey, Mistry et al. 2006) indicate that PPADS had no effect on pH sensitivity of RTN neurons. A 
possible explanation for this apparent discrepancy is that CO2, not H
+
, is the effector responsible for 
hypercapnic-induced ATP release (Spyer, Gourine 2009). Therefore in a parallel series of experiments, 
we tested the effects of two P2-receptor antagonists (PPADS and suramin) on CO2/H
+
 sensitivity of RTN 
neurons in bicarbonate-buffered media. Interestingly, we found that under these conditions both P2-
receptor antagonists blunted neuronal CO2/H
+
 sensitivity. These results are consistent with the possibility 
that CO2 is the required stimulus for ATP release in the RTN.  
 
In summary, we demonstrate that pH-sensitive RTN glia are protoplasmic astrocytes that sense H
+
 by 
inhibition of heteromeric Kir4.1–Kir5.1-like conductance and contribute to respiratory drive by increasing 
activity of pH-sensitive neurons by a purinergic-dependent mechanism. Our results also suggest that the 
NBC may contribute to the pH-sensitive current in RTN astrocytes. Thus we conclude that RTN 
astrocytes contribute to the mechanism of chemoreception and influence integrated output of the RTN.  
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Chapter 5 Regulation of Ventral Surface CO2/H+-sensitive neurons by purinergic signaling 
 
INTRODUCTION 
Carbon dioxide provides the primary stimulus to breathe. Central respiratory chemoreceptors sense 
changes in tissue CO2, H
+
 and/or HCO3
−
 to regulate the rate and depth of breathing (for review see 
(Huckstepp, Dale 2011)). It is now well established that the retrotrapezoid nucleus (RTN) is an important 
site of chemoreception. Specifically, the RTN contains a subset of neurons that is highly CO2/H
+
 sensitive 
in vivo and in vitro, is glutamatergic and projects to respiratory centres to directly influence breathing 
(Mulkey, Stornetta et al. 2004, Takakura, Moreira et al. 2008, Ritucci, Erlichman et al. 2005, Nattie, Fung 
et al. 1993, Abbott, Stornetta et al. 2009, Weston, Stornetta et al. 2004). The mechanism by which RTN 
neurons sense pH involves inhibition of an unidentified voltage-independent K
+
 conductance (Mulkey, 
Stornetta et al. 2004, Mulkey, Talley et al. 2007). Evidence also indicates that purinergic signalling 
contributes to the ventilatory response to CO2 (Gourine, Llaudet et al. 2005, Gourine, Atkinson et al. 
2003, Thomas, Spyer 2000, Thomas, Ralevic et al. 1999). At the level of the RTN, hypercapnia has been 
shown to evoke the discrete release of ATP near the ventral medullary surface (Huckstepp, id Bihi et al. 
2010, Gourine, Kasymov et al. 2010, Gourine, Llaudet et al. 2005), and ATP has been shown to 
contribute to respiratory drive by increasing activity of CO2/H
+
-sensitive RTN neurons (Mulkey, Mistry 
et al. 2006, Gourine, Kasymov et al. 2010, Wenker, Kreneisz et al. 2010).  
 
There is increasing evidence that astrocytes are the source of purinergic drive to RTN chemoreceptors 
(Huckstepp, id Bihi et al. 2010, Wenker, Kreneisz et al. 2010, Gourine, Kasymov et al. 2010); however, 
the extent to which ATP contributes to RTN chemoreception is questionable and the mechanisms 
underlying purinergic modulation of RTN chemoreceptors are not clear (Mulkey, Wenker 2011). For 
example, a recent study reported that H
+
 sensitivity of RTN neurons could be blocked with a P2 receptor 
antagonist (Gourine, Kasymov et al. 2010), suggesting that RTN chemoreception is entirely dependent on 
purinergic signalling. The same study also suggested that the purinergic drive to RTN neurons is 
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dependent on extracellular Ca
2+
; it showed that acidification triggered a Ca
2+
 wave that propagated 
between ventral surface astrocytes, possibly by activating Ca
2+
-permeable channels (e.g. P2X1 or P2X3), 
to potentiate additional ATP release and subsequently activate Phox2b-expressing RTN neurons in vitro 
and increased respiratory activity in vivo. Conversely, we have shown in vitro that RTN neurons are 
highly pH sensitive in the presence of P2 receptor blockers, and that purinergic signalling contributes to 
only a portion of neuronal CO2/H
+
 sensitivity (Mulkey, Mistry et al. 2006, Wenker, Kreneisz et al. 2010). 
Still further evidence obtained using the brainstem–spinal cord preparation reported that purinergic 
signalling does not contribute to CO2 responsiveness of neurons in the parafacial respiratory group 
(pFRG)/RTN of newborn rats (Onimaru, Ikeda et al. 2012). In addition, the mechanism underlying CO2-
evoked ATP release in the RTN appears to be mediated by direct gating of gap junction hemichannels in a 
Ca
2+
-independent manner (Huckstepp, id Bihi et al. 2010).  
 
The objectives of this study are to establish the extent to which purinergic signalling contributes to RTN 
chemoreception both in vivo and in vitro, and to gain insight into the mechanisms underlying CO2-evoked 
ATP release and downstream activation of RTN neurons. To make these determinations, we recorded 
phrenic nerve activity in vivo or the firing rate response of CO2/H
+
-sensitive RTN neurons in the brain 
slice preparation during exposure to hypercapnia alone and in the presence of P2 receptor blockers. In 
addition, we used a pharmacological approach to manipulate potential mechanisms of ATP release and 
activity of downstream P2 receptors. We find that purinergic signalling is an important component of 
RTN chemoreception; application of P2 receptor antagonists into the RTN reduced the ventilatory 
response to CO2 by ∼30% in vivo, and blunted the firing rate response of RTN neurons to both 10% and 
15% CO2 also by 30%. This purinergic drive to breathe was independent of temperature, stimulus 
strength and changes in the extracellular Ca
2+
 gradient, but could be blocked with gap junction 
hemichannel antagonists. These results are most consistent with a recent study by Huckstepp and 
colleagues (Huckstepp, id Bihi et al. 2010), and suggest that astrocytes but not neurons mediate CO2-
evoked ATP release by a mechanism involving gap junction hemichannels.  
 44 
 
 
METHODS 
In vivo preparation  
Animal use was in accordance with guidelines approved by the University of São Paulo Animal Care and 
Use Committee and conforms to the principles of UK regulations, as described in (Drummond 2009). All 
efforts were made to minimize the number of animals used and their suffering. All in vivo experiments 
were performed in male Wistar rats weighing 250–280 g; a total of 38 rats were used for these in vivo 
experiments. The surgical procedures and experimental protocols were similar to those previously 
described (Takakura, Moreira et al. 2011, Takakura, Moreira 2011). Briefly, general anaesthesia was 
induced with 5% halothane in 100% O2. A tracheostomy was made and the halothane concentration was 
reduced to 1.4–1.5% until the end of surgery. The femoral artery was cannulated (polyethylene tubing, 0.6 
mm o.d., 0.3 mm i.d., Scientific Commodities, Lake Havasu City, AZ, USA) for measurement of arterial 
pressure (AP). The femoral vein was cannulated for administration of fluids and drugs. The occipital plate 
was removed, and a micropipette was placed in the medulla oblongata via a dorsal transcerebellar 
approach for microinjection of drugs. A skin incision was made over the lower jaw for placement of a 
bipolar stimulating electrode, next to the mandibular branch of the facial nerve, as previously described 
(Moreira, Takakura et al. 2006, Takakura, Moreira et al. 2011). The phrenic nerve was accessed by a 
dorsolateral approach after retraction of the right shoulder blade. To prevent any influence of artificial 
ventilation on phrenic nerve activity (PNA), the vagus nerve was cut bilaterally. Additionally, a complete 
baro- and peripheral chemoreceptor deafferentation was performed by sectioning the vagosympathetic 
trunks, the superior laryngeal nerves and the glossopharyngeal nerves (proximal to the junction with the 
carotid sinus nerves). Upon completion of the surgical procedures, halothane was replaced with urethane 
(1.2 g kg
−1
) administered slowly i.v. All rats were ventilated with 100% O2 throughout the experiment. 
Rectal temperature was maintained at 37°C. End-tidal CO2 was monitored throughout each experiment 
with a capnometer (CWE, Inc., Ardmore, PA, USA) that was calibrated twice per experiment with a 
calibrated CO2–N2 mix. This instrument provided a reading of <0.1% CO2 during inspiration in animals 
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breathing 100% O2, and an asymptotic, nearly horizontal reading during expiration. The adequacy of 
anaesthesia was monitored during a 20 min stabilization period by testing for the absence of withdrawal 
responses, pressor responses and changes in PNA to a firm toe pinch. After these criteria were satisfied, 
the muscle relaxant pancuronium was administered at an initial dose of 1 mg kg
−1
 i.v. and the adequacy of 
the anaesthesia was thereafter gauged solely by the lack of increase in AP and PNA rate or amplitude to a 
firm toe pinch. Approximately hourly supplements of one-third of the initial dose of urethane were 
needed to satisfy these criteria throughout the recording period (2 h).  
 
In vivo recordings of physiological variables  
As previously described (Mulkey, Stornetta et al. 2004, Moreira, Takakura et al. 2006, Takakura, Moreira 
et al. 2011), mean arterial pressure (MAP), phrenic nerve activity (PNA) and end-expiratory CO2 (etCO2) 
were digitized with a micro1401 (Cambridge Electronic Design), stored on a computer and processed off-
line with version 6 of Spike 2 software (Cambridge Electronic Design). Integrated phrenic nerve activity 
(iPNA) was obtained after rectification and smoothing (τ = 0.015 s) of the original signal, which was 
acquired with a 30–300 Hz bandpass filter. PNA amplitude (PNA amp) and PNA frequency (PNA freq) 
were expressed for each rat on a scale from 0 (value during apnoea) to 100 (value while breathing 10% 
CO2).  
Hypercapnia was produced by addition of pure CO2 to the 100% O2 supplied by artificial ventilation to 
increase the maximum end-expiratory CO2 to 9.5–10%. End-expiratory CO2 was maintained for 5 min, 
and CO2 was removed. Each rat was submitted to three sessions of hypercapnia: one session 10 min after 
bilateral saline injections into the RTN, and two additional sessions, 10 and 60 min after bilateral 
injections of saline, PPDAS or MRS2179 into the RTN.  
 
Histology 
At the end of each in vivo experiment, rats were deeply anaesthetized with halothane and perfused 
through the heart with PBS (pH 7.4) followed by paraformaldehyde (4% in 0.1 m phosphate buffer, pH 
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7.4). The brains were removed and stored in fixative for 24 h at 4°C. The medulla was cut in 40-µm-thick 
coronal sections with a vibrating microtome (Vibratome 1000S Plus, USA). Sections were stored at 
−20°C in a cryoprotectant solution. The injection sites were confirmed with an Axioskop 2 microscope 
(Zeiss, Oberkochen, Germany). Sections from different brains were aligned with respect to a reference 
section, which was the most caudal section containing an identifiable cluster of facial motor neurons. To 
this reference section was assigned a value of 11.6 mm caudal to bregma (bregma −11.6 mm, (Paxinos, 
Watson 1982)). Levels rostral or caudal to this reference section were determined by adding or 
subtracting the number of intervening sections × 40 μm.  
 
Brain slice preparation 
All procedures were performed in accordance with National Institutes of Health and University of 
Connecticut Animal Care and Use Guidelines and conformed to the principles of UK regulations, as 
described in (Drummond 2009). A total of 64 rat pups were used for these in vitro experiments. Slices 
containing the RTN were prepared as previously described (Mulkey, Mistry et al. 2006, Wenker, Kreneisz 
et al. 2010). Briefly, neonatal rats (7–12 days postnatal) were decapitated under ketamine–xylazine 
anaesthesia and transverse brainstem slices (300 μm) were cut using a microslicer (DSK 1500E; Dosaka, 
Kyoto, Japan) in ice-cold substituted Ringer solution containing (in mm): 260 sucrose, 3 KCl, 5 MgCl2, 1 
CaCl2, 1.25 NaH2PO4, 26 NaHCO3, 10 glucose and 1 kynurenic acid. Slices were incubated for ∼30 min 
at 37°C and subsequently at room temperature in normal Ringer solution (in mm): 130 NaCl, 3 KCl, 2 
MgCl2, 2 CaCl2, 1.25 NaH2PO4, 26 NaHCO3 and 10 glucose. Both substituted and normal Ringer 
solutions were bubbled with 95% O2–5% CO2 (extracellular pH (pHo) 7.35).  
 
Slice-patch electrophysiology 
Individual slices were transferred to a recording chamber mounted on a fixed-stage microscope (Zeiss 
Axioskop FS) and perfused continuously (∼2 ml min−1) with a bath solution of normal Ringer solution 
(same as incubation Ringer solution above) bubbled with 95% O2–5% CO2 (pHo 7.35). The pH of the 
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bicarbonate-based bath solution was decreased to 6.90 by bubbling with 15% CO2 or 7.10 by bubbling 
with 10% CO2. All recordings were made with an Axopatch 200B patch-clamp amplifier, digitized with a 
Digidata 1322A A/D converter, and recorded using pCLAMP 10.0 software (Molecular Devices). 
Recordings were obtained at room temperature (∼22°C) with patch electrodes pulled from borosilicate 
glass capillaries (Warner Instruments) on a two-stage puller (P89; Sutter Instrument) to a DC resistance of 
4–6 MΩ when filled with an internal solution containing the following (in mm): 120 KCH3SO3, 4 NaCl, 1 
MgCl2, 0.5 CaCl2, 10 Hepes, 10 EGTA, 3 Mg-ATP and 0.3 GTP-Tris (pH 7.2) plus 0.2% biocytin; 
electrode tips were coated with Sylgard 184 (Dow Corning). All recordings of neuronal firing rate were 
performed in the loose-patch configuration to ensure minimal alteration of the intracellular milieu. Firing 
rate histograms were generated by integrating action potential discharge in 10 s bins and plotted using 
Spike 5.0 software. Excitatory postsynaptic currents (EPSCs) were measured from chemosensitive 
neurons (identified in loose-patch) in whole-cell voltage clamp (Ihold = −60 mV) and analysed off-line 
with AxoGraph X using the following parameters: amplitude = −25 pA, rise constant = 0.7 ms and decay 
constant = 1.6 ms, with a threshold of detection set to −7 SD.  
 
Drugs 
All drugs were purchased from Sigma. For in vivo experiments, the non-specific P2 receptor antagonist 
pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid (PPADS), the P2Y1-receptor antagonist MRS2179 
and the P2Y1-receptor agonist MRS2365 were diluted to 100 μm in sterile saline (pH 7.4) and injected 
into the RTN using single-barrel glass pipettes (tip diameter of 20 μm) connected to a pressure injector 
(Picospritzer III, Parker Hannifin Corp, Cleveland, OH, USA). For each injection we delivered a volume 
of 50 nl over a period of 5 s. These glass pipettes also allowed recordings of field potential properties that 
were used to help direct the electrode tip to the desired site. Injections in the RTN region were guided by 
recordings of the facial field potential (Brown, Guyenet 1985), and were placed 250 μm below the lower 
edge of the field, 1.7 mm lateral to the midline and 200 μm rostral to the caudal end of the field. 
Recordings were made on one side only; the second injection was made 1–2 min later at the same level on 
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the contralateral side. We included a 5% dilution of fluorescent latex microbeads (Lumafluor, New City, 
NY, USA) with all drug applications to mark the injection sites and verify the spread of the injections 
(Takakura, Moreira et al. 2011, Takakura, Moreira 2011). For the in vitro experiments, we bath applied 
PPADS (100 μm) or suramin (100 μm) to block P2 receptors, MRS2179 (3 μm) to block P2Y1 receptors, 
and carbenoxolone (CBX, 100 μm) or cobalt (500 μm) to block gap junction hemichannels. A low Ca2+, 
high Mg
2+
 synaptic block solution was used to block potential ATP release from neurons and to limit Ca
2+
 
influx into astrocytes from the extracellular space. The composition of the synaptic block medium used in 
this study is similar to normal Ringer solution except that MgCl2 was increased to 11.4 mm, CaCl2 was 
decreased to 0.2 mm, and to maintain osmolality, NaCl was decreased to 124 mm. The efficacy of this 
synaptic blocking medium is well established (Hatton 1982, Richards, Sercombe 1970, Mason 1980) and 
confirmed here by recording its effects on spontaneous EPSCs. In addition, the specific P2Y1 receptor 
agonist (MRS2365; 100 μm in Hepes-buffered medium, pH 7.3) was delivered focally using low-
resistance pipettes connected to a Picospritzer III (Parker Instrumentation, Cleveland, OH, USA) and 
manoeuvered into close proximity of the target neurons. Application times were 600 ms, and vehicle 
control experiments were performed to ensure agonist responses were not attributable to pressure 
artifacts.  
 
Statistics 
Data are reported as mean ± standard error of the mean. Statistical analysis was performed using Sigma 
Stat version 3.0 software (Jandel Corporation, Point Richmond, CA, USA). t test, paired t test or one-way 
ANOVA followed by the Newman–Keul multiple comparisons test were used as appropriate (P < 0.05).  
 
RESULTS 
This study consists of three sets of experiments. First, to determine the extent to which purinergic 
signalling contributes to central chemoreception, my collaborators at the University of Sao Paulo tested 
the effects of P2 receptor antagonists (PPADS or suramin) on the hypercapnic ventilatory response in 
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vivo, and on the firing rate response of RTN neurons to 10% and 15% CO2 at room or body temperature 
in vitro. Second, to determine if purinergic drive to RTN neurons is dependent on synaptic input or 
requires extracellular Ca
2+
, as previously reported, I compared effects of P2 receptor antagonists on 
neuronal CO2/H
+
 responsiveness under control conditions and in low Ca
2+–high Mg2+ synaptic block 
medium. Third, to determine if purinergic drive to CO2/H
+
-sensitive RTN neurons is mediated by 
hemichannels, I tested neuronal CO2/H
+
 sensitivity in the presence of the gap junction blockers CBX or 
cobalt. Note that chemosensitive RTN neurons have been shown to express the transcription factor 
Phox2b (Stornetta, Moreira et al. 2006, Lazarenko, Milner et al. 2009); however, Phox2b has also been 
shown to be expressed by other cells in relatively close proximity to the RTN, including 
catecholaminergic neurons (C1 and A5), facial motor neurons and the superior salivatory nucleus (Kang, 
Chang et al. 2007). Therefore, we chose to functionally identify CO2/H
+
-sensitive RTN neurons based on 
their characteristic firing rate response to CO2/H
+
. Neurons were considered chemosensitive if they were 
spontaneously active in 5% CO2 (pHo 7.35) and responded to 15% CO2 (pHo ∼6.90) with at least 1.5 Hz 
increase in firing rate. This level of CO2/H
+
 responsiveness is similar to what we, and others, have 
reported for RTN chemosensitive neurons (Ritucci, Erlichman et al. 2005, Wenker, Kreneisz et al. 2010, 
Mulkey, Mistry et al. 2006). RTN neurons that did not exhibit this minimum firing rate response to 15% 
CO2 were considered non-chemosensitive and excluded from this study.  
 
Purinergic drive to RTN chemoreceptors in vivo 
As expected, when urethane-anaesthetized, sino-aortic denervated and vagotomized rats (n = 6 per group) 
are exposure to hypercapnia (10% CO2) PNA amplitude and PNA frequency increased by 100 ± 2% and 
99 ± 2% (Fig. 7A, D and E). Injections of PPADS (3 mm in 50 nl) were placed bilaterally in the RTN in 
these rats (Fig. 7B and C). The injection centre was 250 μm below the facial motor nucleus and 200 μm 
rostral to the caudal end of this nucleus, targeting the region that contains the highest density of CO2-
sensitive RTN neurons (Mulkey, Stornetta et al. 2004, Takakura, Moreira et al. 2011, Takakura, Moreira 
2011). Application of PPADS into the RTN did not change resting PNA activity (99 ± 7% of control   
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Figure 7 
P2 receptor antagonist injections into the RTN attenuate effects of hypercapnia on arterial pressure 
and PNA in anaesthetized vago-sino-aortic denervated rats. A, recordings from one rat showing the 
effect of injection of PPADS into the RTN on changes in arterial pressure (AP) and phrenic nerve activity 
(PNA) elicited by an increase of end-expiratory CO2 from 5 to 10%. Responses were recorded 10 min 
after bilateral injection of saline into the RTN, and 10 min after bilateral injection of PPADS (3 mm, 50 nl 
each side) in the RTN. B, photomicrograph of a coronal section showing bilateral injections in the RTN. 
Scale bar is 500 μm. C, computer-assisted plot of the centre of injection sites revealed by presence of 
fluorescent microbeads included in the injectate (coronal plane at Bregma −11.6; (Paxinos, Watson 
1982)). Scale bar is 1 mm. D–F, summary data (n = 6) show changes in PNA amplitude (ΔPNA ampl) 
(D), PNA frequency (ΔPNA freq) (E) and mean arterial pressure (ΔMAP) (F) elicited by stepping the 
end-expiratory CO2 from 5 to 10% during saline or PPADS injections into the RTN. Differences 
expressed as a percentage of the response to the CO2 challenge elicited during saline injection. *Different 
from saline (P < 0.05). Abbreviations: py, pyramid; RPa, raphe pallidus; Sp5, spinal trigeminal tract; VII, 
facial motor nucleus. 
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value; P > 0.05), but did reduce the hypercapnia-induced increase in PNA amplitude (62 ± 9% of the 
control) and PNA frequency (77 ± 3% of the control) (Fig. 7D and E). As shown in Fig. 7A, exposure to 
hypercapnia also caused hypotension (−11 ± 7 mmHg) followed by a gradual return of mean arterial 
pressure (MAP) to control level, 30 to 40 s later. Immediately after hypercapnia ended, the MAP 
increased by 21 ± 6 mmHg, and returned to control values within 5 min (Fig. 7A and F). Injection of 
PPADS into the RTN did not change resting MAP (124 ± 6 mmHg compared with saline 126 ± 5 mmHg), 
but did reduce the hypercapnia-induced pressor response from 21 ± 6 to 8 ± 4 mmHg (Fig. 7A and F).  
Injections located outside the RTN region often (3 out of 4) reached the facial motor nucleus or dorsal to 
it and one injection (1 out of 4) was located in the parapyramidal region (data not shown). Bilateral 
injections of PPADS in the facial motor nucleus or in the parapyramidal region did not change the 
hypercapnic-induced respiratory or pressor responses in these animals (data not shown).  
 
Purinergic drive to RTN chemoreceptors in vitro 
Previous evidence indicates that temperature greatly increased pH sensitivity of RTN neurons in vitro 
(Guyenet, Mulkey et al. 2005). Therefore, we wanted to determine if the contribution of purinergic drive 
to CO2/H
+
-sensitive RTN neurons also increased with temperature. We found that increasing temperature 
from ∼22°C to 35°C increased baseline activity by 2.01 ± 0.18 Hz (Fig. 8A) and increased the firing rate 
response to 15% CO2 from 1.9 ± 0.09 Hz to 3.3 ± 0.23 Hz (n = 4) (Fig. 8B). The temperature coefficient 
(Q10) for the CO2/H
+
 sensitivity of RTN neurons was estimated to be ∼1.5 ± 0.1 (n = 9); this value is very 
similar to the pH-sensitive Q10 of RTN neurons over a similar pH range (∼1.55, extrapolated from Fig. 
8D; (Guyenet, Mulkey et al. 2005)]. At 35°C, exposure to the P2 receptor antagonists PPADS (100 μm) 
or suramin (100 μm) decreased firing rate by 0.73 ± 0.18 Hz, consistent with the hypothesis that CO2/H
+
-
sensitive RTN neurons receive tonic purinergic input (Wenker, Kreneisz et al. 2010). Prior to testing 
CO2/H
+
 sensitivity at 35°C, a hyperpolarizing current (∼5 pA) was delivered to approximate the control 
level of neuronal activity. In the continued presence of PPADS or suramin at 35°C (with baseline activity 
adjusted by DC current injection to near-control levels), exposure to 15% CO2 increased neuronal activity  
 53 
 
Figure 8 
Purinergic contribution to CO2/H
+
 sensitivity of RTN neurons is not temperature dependent. A, 
traces of firing rate and bath temperature show CO2/H
+
 responsiveness at room temperature (∼22°C) and 
35°C with and without suramin (Sur, 100 μm), a P2 receptor antagonist. At room temperature, increasing 
bath CO2 from 5 to 15% increased firing rate ∼2 Hz. Heating to 35°C increased firing rate ∼2 Hz. Prior to 
testing CO2/H
+
 sensitivity at 35°C we delivered a hyperpolarizing current (−5 nA; left arrow) into the cell 
to match firing rate to control activity. Under these conditions exposure to 15% CO2 increased firing rate 
∼3.5 Hz. A 10 min incubation in suramin (*) decreased the firing rate response to 15% CO2 by 40%. 
CO2/H
+
 sensitivity returned to control levels in wash. B, average data show the CO2/H
+
-induced firing rate 
response at room temperature (a portion of these results were published previously Wenker et al. 2010) 
and at 35°C with or without the P2 receptor antagonist PPADS (100 μm, n = 4) or suramin (100 μm, n = 
4). Based on these results we calculated the Q10 of CO2/H
+
 sensitivity and purinergic drive to RTN 
neurons to be ∼1.5 and ∼1.3, respectively. C, purinergic drive to chemosensitive RTN neurons shown as 
% inhibition of CO2/H
+
 sensitivity by PPADS (n = 11) or suramin (n = 11) at 22°C and 35°C. Note that 
increasing temperature did not increase the purinergic drive to chemosensitive RTN neurons. 
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by 2.38 ± 0.23 Hz (n = 8); this response was significantly less than the CO2/H
+
 response at 35°C in the 
absence of the P2 receptor antagonist (initial response or after wash out) (Fig. 8A–B). This purinergic-
sensitive component of RTN chemoreception has an estimated Q10 of ∼1.3. It is worth noting that this 
value is similar to that described for connexin-mediated ATP release or current flux (Q10 = 1.2–1.4;  
(Bukauskas, Elfgang et al. 1995, Valiunas, Manthey et al. 1999, Leybaert, Braet et al. 2003). In addition, 
heating from 22°C to 35°C did not significantly increase effects of P2 receptor antagonists on CO2/H
+
 
sensitivity of RTN neurons; PPADS and suramin decreased chemoreceptor activity by 27.3 ± 4.8% (n = 
12) and 27.9 ± 4.5% (n = 8) at 22°C and 35°C, respectively (Fig. 8C). These results indicate that 
purinergic drive to CO2/H
+
-sensitive RTN neurons does not vary over this temperature range; therefore, 
all subsequent in vitro experiments were performed at room temperature.  
 
To address the possibility that purinergic drive to RTN neurons is stimulus dependent, we compared 
effects of suramin on the firing rate response of RTN neurons to 10% and 15% CO2. As shown in Fig. 9A 
and B, exposure to 10% (pHo 7.10) and 15% CO2 (pHo 6.90) increased chemoreceptor activity by 1.83 ± 
0.17 Hz and 2.48 ± 0.20 Hz (n = 3), respectively. In addition, suramin had similar effects on the firing rate 
response of RTN neurons to 10% and 15% CO2. Previous (Wenker, Kreneisz et al. 2010) and current 
results (Fig. 9C and D) show that ∼10 min incubation in suramin (100 μm) decreased the response of 
RTN neurons to 10% and 15% CO2 by 33.5 ± 3.3% and 31.9 ± 7.2%, respectively (Fig. 9C and D), 
suggesting that purinergic drive to these cells is relatively constant over this CO2 range.  
 
Changes in the extracellular Ca
2+
 gradient do not affect purinergic drive to chemoreceptors  
Evidence suggests that H
+
-evoked ATP release triggers Ca
2+
 influx into ventral surface astrocytes, 
possibly via P2X receptors, and this leads to bulk ATP release and subsequent activation of CO2/H
+
-
sensitive RTN neurons (Gourine, Kasymov et al. 2010)). To explore this possibility further, we tested the 
effects of a high MgCl2 and low CaCl2 medium on the CO2/H
+
 sensitivity of RTN neurons. We used low 
(200 μm) rather than zero Ca2+ in order to minimize the effects of low Ca2+ on gap junctions. In addition,  
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Figure 9 
Purinergic drive does not increase with increased CO2 intensity. A, firing rate trace shows that 
exposure to 10 and 15% CO2 increased neuronal activity by 2.9 and 2.1 Hz, respectively. In the presence 
of suramin (100 μm), exposure to 10% CO2 increased neuronal activity only 1.6 Hz. Responsiveness to 10 
and 15% CO2 was fully recovered when suramin was washed out. The asterisks denote 10 min time 
breaks. B, average data (n = 3) show that exposure to 10 and 15% CO2 increased neuronal activity in a 
relatively linear manner. C, summary data (n = 3) show that suramin decreased the firing rate response to 
10% CO2. D, summary data (n = 3) show that suramin decreased the responsiveness to 10 and 15% CO2 
by similar amounts, indicating that purinergic drive to chemosensitive RTN neurons does not increase in 
response to this range of stimulus intensities. 
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this medium has been shown to effectively block Ca
2+
-dependent exocytosis with little disruption of 
intrinsic membrane characteristics (Richards, Sercombe 1970). As before, CO2/H
+
-sensitive RTN neurons 
were identified based on their robust firing rate response to 15% CO2 in normal Ringer solution. Exposure 
to low Ca
2+–high Mg2+ medium alone did not consistently increase baseline activity, suggesting that this 
low level of extracellular Ca
2+
 did not facilitate gap junction-mediated ATP release. However, as noted 
below low Ca
2+–high Mg2+ medium can inhibit excitatory input to RTN chemoreceptors (Fig. 10C), and 
so potentially offset excitatory effects of connexin-mediated ATP release. A second exposure to 15% 
CO2, this time after ∼10 min incubation in low Ca
2+–high Mg2+ solution, also elicited a strong firing rate 
response (Fig. 10A and B), indicating that a 10-fold decrease in the extracellular Ca
2+
 gradient did not 
affect CO2/H
+
 sensitivity (Fig. 10B). To confirm that Ca
2+
-dependent exocytosis was effectively 
attenuated by these incubation conditions, we recorded excitatory post-synaptic currents (EPSCs) from 
RTN chemoreceptor neurons during exposure to the low Ca
2+–high Mg2+ solution. As expected, ∼5 min 
perfusion with low Ca
2+–high Mg2+ solution caused a robust and reversible decrease in EPSC frequency 
with only a modest effect on amplitude (Fig. 10C–E). These results suggest that the CO2/H
+
 sensitivity of 
RTN neurons, including the purinergic component, is not dependent on neuronal vesicle release.  
 
Gap junction hemichannels contribute to CO2/H
+
-evoked ATP release in the RTN  
There is evidence that connexin 26 hemichannels are directly gated by CO2 (Huckstepp, Eason et al. 
2010) and contribute to CO2-evoked ATP release in the RTN (Huckstepp, id Bihi et al. 2010). To test 
whether connexin-mediated transmitter release contributes to the CO2/H
+
 sensitivity of RTN neurons, we 
used CBX and cobalt to block hemichannels. We found that ∼10 min incubation in CBX (100 μm) 
decreased neuronal CO2/H
+
 sensitivity by 0.74 ± 0.18 Hz (n = 6) or 27.7 ± 5.5% (Fig. 11A and B). 
Likewise, incubation in cobalt (500 μm) decreased neuronal CO2/H
+
 sensitivity by 0.64 ± 0.08 Hz (n = 5) 
or 26.36 ± 2.73% (Fig. 11C and D). Note that both gap junction blockers decreased neuronal CO2/H
+
 
sensitivity by an amount similar to the previously reported effects of P2 receptor antagonists (PPADS and 
suramin); at room temperature P2 receptor antagonists decreased CO2/H
+
 sensitivity of RTN neurons by  
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Figure 10 
Purinergic drive to RTN neurons is not dependent on extracellular Ca
2+
. A, firing rate trace shows 
that the CO2/H
+
 sensitivity of an RTN neuron was unaffected by low Ca
2+–high Mg2+ synaptic block (SB) 
medium. The asterisks denote 8 min time breaks. B, average data (n = 5) show that SB medium did not 
significantly affect CO2/H
+
 sensitivity (P = 0.982). C, traces of holding current (at a potential of −60 mV) 
show that exposure to SB medium blocked spontaneous excitatory post-synaptic currents (EPSCs) in 
chemosensitive RTN neurons. D and E, as expected, SB medium inhibited EPSC frequency (D, n = 3) but 
not EPSC amplitude (E, n = 3). Average decay time constant was 4.8 ± 0.2 ms (not shown). These results 
suggest that extracellular Ca
2+
 is not required for the purinergic drive to breathe. 
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Figure 11 
Gap junction blockers decrease purinergic drive to RTN neurons. A, trace of firing rate shows that 
under control conditions, exposure to 15% CO2 increased the neuronal activity ∼3 Hz. A second exposure 
to 15% CO2, this time after 10 min incubation with carbenoxolone (CBX, 100 μm), increased firing rate 
only ∼2 Hz. The asterisk indicates a gap in recording during the CBX wash. B, average data (n = 6) show 
that CBX decreased CO2/H
+
 sensitivity by ∼30%. C, trace of firing rate shows that exposure to 15% CO2 
increased neuronal activity 2.1 Hz. After returning to control conditions, exposure to cobalt (500 μm) 
inhibited neuronal activity; therefore a depolarizing current (5 nA; arrow) was injected into the cell to 
approximate baseline activity under control conditions. In the continued presence of cobalt (with a 
holding current of 5.0 nA), a second exposure to 15% CO2 this time only increased firing rate ∼1.5 Hz. 
CO2 responsivness was fully recovered after washing out cobalt for ∼10 min. D, average data (n = 5) 
show that cobalt decreased CO2/H
+
 sensitivity by ∼30%. 
  
 62 
 
  
 63 
 
0.7 ± 0.18 Hz or 27.3 ± 4.8% (Wenker, Kreneisz et al. 2010). Furthermore, in combination suramin and 
cobalt decreased CO2/H
+
 sensitivity of RTN neurons by 28 ± 3.0% (Fig. 12A and B). The per cent 
inhibition by suramin and cobalt acting together was not different from that of either blocker alone (Fig. 
12C), further suggesting that the majority of CO2-evoked ATP release is mediated by gap junction 
hemichannels. Together, these results strongly suggest that gap junction hemichannels mediate CO2-
evoked ATP release in the RTN.  
 
P2Y1 receptors in the RTN do not contribute to central chemoreception in vitro or in vivo 
Evidence suggests that P2Y receptors mediate the excitatory effects of ATP on CO2/H
+
-sensitive RTN 
neurons (Mulkey, Mistry et al. 2006, Wenker, Kreneisz et al. 2010). Of these, P2Y1 receptors have been 
shown to function as the primary substrate for ATP-mediated activation of inspiratory neurons in the 
preBötzinger complex (Lorier, Lipski et al. 2008, Lorier, Huxtable et al. 2007), a region critically 
involved in inspiratory rhythm generation (Smith, Ellenberger et al. 1991). Therefore, we considered the 
possibility that P2Y1 receptors also contribute to up-stream purinergic modulation of CO2/H
+
-sensitive 
RTN neurons. To make this determination, we tested effects of MRS2179 (a potent and specific P2Y1 
receptor blocker) on CO2 sensitivity of RTN neurons in vitro and in vivo. In the brain slice preparation, 
incubation (∼10 min) in MRS2179 (3 μm) had negligible effects on baseline activity and CO2/H
+
 
sensitivity of RTN neurons (Fig. 13A and B). In addition, focal application of a specific P2Y1 receptor 
agonist (MRS2365, 100 μm) had no effect on activity of CO2/H
+
-sensitive RTN neurons (Fig. 13A). 
These results suggest P2Y1 receptors are not expressed by CO2/H
+
-sensitive RTN neurons and do not 
contribute to their CO2 sensitivity.  
 
To determine if P2Y1 receptors contribute to CO2-induced changes in breathing or blood pressure in vivo, 
we measured CO2 responsivness after bilateral RTN injections of saline or MRS2179. As described 
above, under control conditions (i.e. after saline injections), exposure to hypercapnia (10% CO2) increases 
PNA and causes hypotension (−16 ± 6 mmHg) followed by an increase in MAP (24 ± 5 mmHg) (Figs 7    
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Figure 12 
In combination, P2 receptor antagonist and gap junction blockers decrease CO2/H
+
 sensitivity by 
an amount similar to each blocker alone. A, trace of firing rate shows that under control conditions 
exposure to 15% CO2 increased neuronal activity ∼2 Hz. A second exposure to 15% CO2, this time in the 
presence of suramin to block P2 receptors and cobalt to block gap junction hemichannels, increased firing 
rate only ∼1 Hz or 72% of control. The asterisk indicates an 8 min time break. CO2 sensitivity fully 
recovered after washing out suramin and cobalt. B, summary data (n = 3) show that in combination 
suramin and cobalt decreased CO2/H
+
 sensitivity of RTN neurons by 28 ± 3.0%. C, the per cent inhibition 
by suramin and cobalt acting together is not different from that of either blocker alone. 
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Figure 13 
Purinergic drive to RTN neurons does not depend on P2Y1 receptors. A, trace of firing rate shows 
that under control conditions exposure to 15% CO2 increased neuronal activity ∼3 Hz. A second exposure 
to 15% CO2, this time in the presence of the P2Y1 receptor-specific antagonist MRS2179 (3 μm), also 
increased firing rate by ∼3 Hz. The asterisk indicates a 10 min time break during which the tissue was 
incubated in MRS2179. Arrows indicate when the P2Y1-specific agonist MRS2365 (100 μm in 7.3 Hepes 
buffer) was focally applied. B, summary data (n = 6) show that MRS2179 had no effect on the CO2/H
+
 
sensitivity of RTN neurons. 
  
 67 
 
 
 
 
  
 68 
 
and 14). Bilateral RTN injections of MRS2179 (100 μm in 50 nl) did not change resting MAP (119 ± 5 
mmHg compared with saline 121 ± 3 mmHg) or baseline PNA activity (102 ± 5% of control). In addition, 
injections of MRS2179 did not affect the CO2-induced pressor response (24 ± 5 mmHg vs. saline 19 ± 4 
mmHg) or the CO2-induced increase in PNA amplitude (86 ± 15% of control) and PNA frequency (108 ± 
5% of the control) (Fig. 14A and C–E). However, unilateral RTN injections of MRS2365 (100 μm in 50 
nl) increased MAP by 23 ± 1 mmHg (compared with 4 ± 1 mmHg in control experiments) and increased 
PNA amplitude and frequency by 59 ± 6% and 53 ± 5%, respectively (Fig. 15C–E). Further, bilateral 
injections of MRS2179 entirely blocked the effects of MRS2365 (Fig. 15A–E), thus confirming 
effectiveness of the antagonist. These results are consistent with our in vitro evidence that P2Y1 receptors 
are not expressed by CO2/H
+
-sensitive RTN neurons and do not contribute to central CO2 sensitivity.  
 
DISCUSSION 
There is compelling evidence that CO2-evoked ATP release from ventral surface astrocytes contributes to 
respiratory drive by activating chemosensitive RTN neurons (Gourine, Kasymov et al. 2010, Gourine, 
Llaudet et al. 2005, Wenker, Kreneisz et al. 2010). Here, we demonstrate in vivo that blocking P2 
receptors in the RTN lessened the changes in PNA amplitude, PNA frequency and pressor responses 
elicited by central chemoreflex activation. Additionally, we show in vitro that bath application of P2 
receptor antagonists (PPADS and suramin) blunted the firing rate response of RTN neurons to 10% and 
15% CO2 by 30%. We show that the contribution of purinergic signalling to chemosensitive RTN 
neuronal activity is independent of temperature and stimulus strength. These results clearly indicate that 
purinergic signalling contributes in part to the integrated output of the RTN during hypercapnia. We also 
found that the purinergic drive to chemosensitive RTN neurons was wholly retained in low Ca
2+
 synaptic 
block medium but was significantly attenuated by gap junction blockers (CBX and cobalt), suggesting 
that astrocytes release ATP via gap junction hemichannels. Our results also show that P2Y1 receptors do 
not contribute to CO2/H
+
 sensitivity of the RTN; however, P2Y1 receptors are expressed in the region and 
their activation can influence respiratory and sympathetic outflow of the RTN. The identity and function  
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Figure 14 
P2Y1 receptors do not contribute to CO2-induced changes in breathing or blood pressure. A, traces 
of end-expiratory CO2 (etCO2), arterial pressure (AP) and integrated PNA (iPNA) show CO2 responses 10 
min after RTN injections of saline or MRS2179 (100 μm, 50 nl each side). B, computer-assisted plot of 
the centre of injection sites (Bregma −11.6; Paxinos & Watson, 1998). Scale bar in B, 1 mm. C–E, 
summary data (n = 5) showing changes in mean arterial pressure (ΔMAP) (C), PNA amplitude (ΔPNA 
ampl) (D) and PNA frequency (ΔPNA freq) (E) elicited by stepping the end-expiratory CO2 from 5 to 
10% after RTN injections of saline or MRS2179. Differences are expressed as a percentage of the 
response to CO2 after saline injection. Abbreviations: py, pyramid; RPa, raphe pallidus; Sp5, spinal 
trigeminal tract; VII, facial motor nucleus. 
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Figure 15 
RTN injections of a specific P2Y1 agonist increased arterial pressure and PNA in anaesthetized 
vago-sino-aortic-denervated rats. A, traces of arterial pressure (AP) and integrated phrenic nerve 
activity (iPNA) show that unilateral RTN injections of the specific P2Y1 receptor agonist MRS2365 (100 
μm in 50 nl) increased AP and PNA. B, computer-assisted plot of injection sites (coronal plane at Bregma 
−11.6 (Paxinos & Watson, 1998). Scale bar in B, 1 mm. C–E, summary data (n = 6) show MRS2365-
induced ΔMAP (B), ΔPNA amp (C) and ΔPNA freq (D) after RTN injections of saline or MRS2179. 
Differences expressed as a percentage of the response to the CO2 challenge elicited during saline 
injection. Abbreviations: py, pyramid; Sp5, spinal trigeminal tract; VII, facial motor nucleus. 
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of these P2Y1-expressing neurons remain unknown. We conclude that RTN chemoreception is 
determined primarily by CO2/H
+
-sensitive neurons but is augmented by gap junction-mediated, CO2-
evoked ATP release most probably from astrocytes. 
 
Experimental limitations 
Our in vivo experiments were performed is anaesthetized rats and it is well known that anaesthetics can 
modify centrally mediated cardio-respiratory reflexes. Therefore, it will be important for future studies to 
confirm the role of purinergic signalling in central chemoreception using conscious animals. In addition, 
we did not measure ATP directly but rather used the activity of RTN chemoreceptors as a functional 
measure of ATP release. This approach is reasonable considering that CO2-evoked ATP release in the 
region of the RTN is well established (Gourine, Kasymov et al. 2010, Gourine, Llaudet et al. 2005, 
Huckstepp, id Bihi et al. 2010) and the focus of the current study is on the purinergic drive to RTN 
neurons, which has received only limited attention. This study was also limited by the lack of 
pharmacological tools that allow for the specific manipulation of astrocytes without confounding effects 
on neurons. Nevertheless, the results presented here provide important direction for future experiments 
that take advantage of astrocyte-specific transgenic animal models, e.g. IP3-receptor type 2 (IP3R2) 
knockout mice (Petravicz, Fiacco et al. 2008)  or the dominant negative synaptobrevin 2 model (Pascual, 
Casper et al. 2005), to further dissect neuron–astrocyte interactions in the context of chemoreception.  
 
Contribution of purinergic signalling to RTN chemoreception 
Bilateral injection of PPADS into the RTN of adult rats decreased the ventilatory response to CO2 by 
∼30%. These results are entirely consistent with previous evidence showing that direct application of 
PPADS onto the exposed ventral surface also decreased the hypercapnic ventilatory response in vivo by 
up to ∼30% (Gourine, Llaudet et al. 2005). In addition, we show by using brain slices from neonatal rat 
pups that bath application of PPADS or suramin decreased the response of functionally identified 
CO2/H
+
-sensitive RTN neurons by ∼30% regardless of stimulus strength or bath temperature. 
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Considering that P2 receptor blockers had similar effects on chemosensitivity in neonatal (postnatal days 
7–12) and adult rats suggests that the purinergic drive to RTN neurons does not increase over this age 
range. However, astrocyte are known to undergo dramatic changes during the first postnatal week, and in 
other brain regions it is not until ∼day 4 that characteristically mature astrocytes first appear (i.e. 
electrically passive) (Zhou, Schools et al. 2006). In the RTN, CO2/H
+
-sensitive astrocytes exhibit an 
electrically passive signature and presumably these cells are the source of ATP released in this region 
during hypercapnia (Wenker, Kreneisz et al. 2010). Therefore, if mature astrocytes are absent from the 
RTN in newborn animals, than we expect CO2/H
+
 sensitivity to be determined exclusively by intrinsic 
neuronal properties. This is exactly what (Onimaru, Ikeda et al. 2012) demonstrated using the in vitro 
brainstem–spinal cord preparation from newborn rats; bath application of P2 receptor blockers (MRS2179 
or PPADS) had no effect on CO2 responsivness of pFRG/RTN neurons. Our results clearly show in 
neonatal and adult rats that CO2-evoked ATP release contributes to a portion of the hypercapnic 
ventilatory response by increasing baseline activity of chemosensitive RTN neurons at any given level of 
CO2. However, it remains questionable whether purinergic signalling directly contributes to the H
+
-
sensing mechanism of RTN neurons. In addition, the purinergic-independent component of RTN 
chemoreception (∼70%) was retained when synaptic activity was blocked which strengthens the 
possibility that RTN neurons are CO2/H
+
 sensitive (Mulkey, Mistry et al. 2006).  
 
It is well established that hypercapnia produces biphasic changes in vascular tone, i.e hypotension 
followed by hypertension. The initial hypotension probably results from a direct effect of CO2/H
+
 on 
vasculature smooth muscle cells. Compensatory activation of sympathetic activity allows arterial pressure 
to recover to near control levels during hypercapnia, and accounts for the increase in arterial pressure 
observed at the end of the hypercapnia episode (Takakura, Moreira 2011, Mulkey, Mistry et al. 2006). 
Application of PPADS into the RTN region decreased the sympathetic-mediated pressure response to 
hypercapnia, suggesting a novel role of purinergic signalling in regulation of vascular tone during 
hypercapnia. For example, it is possible that CO2-evoked ATP release provides excitatory drive to the 
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nearby RVLM/C1 presympathetic neurons. In the presence of PPADS this excitatory drive would be 
reduced and so potentially decrease sympathetic output. However, this possibility remains speculative and 
in need of further investigation.  
 
The identity of P2 receptors expressed by CO2/H
+
-sensitive RTN neurons remains unknown. It was 
shown previously that P2Y1 receptors mediate the excitatory effects of ATP on neurons in the 
preBötzinger complex (Lorier, Lipski et al. 2008, Lorier, Huxtable et al. 2007). However, we found that 
P2Y1 receptors are not expressed by chemosensitive RTN neurons and do not contribute to CO2/H
+
 
sensitivity of these cells in vitro or to CO2-induced changes in breathing or blood pressure in vivo. 
Therefore, P2Y1 receptors do not contribute to RTN chemoreception. However, activation of P2Y1 
receptors in the RTN increased breathing and MAP, suggesting that P2Y1 receptors are expressed in the 
region and, when activated, can influence respiratory and sympathetic outflow. Considering that ADP not 
ATP is the preferential ligand for P2Y1 receptors, we speculate that ATP released during hypercapnia is 
not readily broken down to ADP and adenosine, thus limiting the contribution of these unknown P2Y1-
expressing neurons to regulation of breathing or blood pressure. A focus of future work will be to 
determine the identity and function of these P2Y1-expressing RTN neurons. Nevertheless, the absence of 
an identifiable G-protein-coupled purinergic receptor on chemosensitive RTN neurons suggests that one 
or more P2X receptors may contribute to purinergic modulation of chemosensitive RTN neurons, 
possibly P2X1 and/or P2X3 (Gourine, Kasymov et al. 2010).  
 
Requisite role of gap junction hemichannels in purinergic drive to RTN chemoreceptors 
Our evidence that gap junction blockers (CBX and cobalt), but not synaptic block medium, decreased 
chemosensitive RTN neuronal activity by an amount proportional to inhibition by P2 receptor 
antagonists, suggests that the purinergic drive to RTN neurons is dependent on hemichannels. We 
consider it unlikely that communication between astrocytes via gap junctions is a major determinant of 
purinergic drive to neurons in this region for two reasons. First, RTN astrocytes are unusual in that they 
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exhibit limited dye-coupling compared with astrocytes in other brain regions (Wenker, Kreneisz et al. 
2010), suggesting that these cells are not extensively gap junction coupled. In addition, previous evidence 
showed that cobalt preferentially blocks hemichannel current with little effect on transjunctional current 
through gap junctions in embryonic stem cells (Huettner, Lu et al. 2006). Our results are consistent with a 
recent in vivo study that showed that application of connexin hemichannel antagonists near the RTN 
inhibited CO2-evoked ATP release and decreased the whole animal ventilatory response to CO2 by ∼25% 
(Huckstepp, id Bihi et al. 2010).  
 
There is convincing evidence that CO2-evoked ATP release in the RTN is dependent on connexin 26 
(Cx26) (Huckstepp, Eason et al. 2010). The mechanism by which CO2 influences the gating of Cx26 
hemichannels is not fully understood. Evidence suggests that molecular CO2 binds directly to Cx26 to 
increase the open probability of the hemichannel (Huckstepp, Eason et al. 2010). However, it has also 
been shown that CO2/H
+
 sensitivity of RTN astrocytes is determined, in part, by inhibition of Kir4.1–
Kir5.1 channels (Wenker, Kreneisz et al. 2010), suggesting that membrane depolarization could trigger 
ATP release. This mechanism could be parsimonious with the current data considering that certain 
hemichannels exhibit voltage-dependent gating (Saez, Retamal et al. 2005). However, rat Cx26 does not 
demonstrate voltage dependence (Gonzalez, Gomez-Hernandez et al. 2006); thus, if Cx26 is the main 
conduit for ATP release from RTN astrocytes then acid-induced changes in membrane potential might not 
contribute. Consistent with this possibility, a recent in vivo study reported that Kir5.1 knockout mice 
exhibit normal ventilatory response to CO2 in vivo (Trapp, Tucker et al. 2011), suggesting that astrocytic 
membrane depolarization is not required for CO2-evoked ATP release. However, it should be recognized 
that Kir5.1 channels are expressed in other organs, including the kidneys, and as described by Trapp et al. 
these conventional knockout mice have profound metabolic acidosis which could conceivably interfere 
with this acid-sensing mechanism. Thus, the link between CO2/H
+
-induced changes in astrocytic 
membrane potential and ATP release remains to be definitively established.  
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Role of astrocytes in RTN purinergic signalling 
There is general agreement that astrocytes (or more precisely glial-like cells that express astrocytic 
markers) are the most likely source of ATP release (Wenker, Kreneisz et al. 2010, Gourine, Kasymov et 
al. 2010). For example, Gourine and colleagues demonstrated, using astrocyte-specific expression of 
channel rhodopsin 2, a light-sensitive cation channel, that generating calcium waves in astrocytes results 
in ATP release that can activate RTN neurons in vitro and increase breathing in vivo (Gourine, Kasymov 
et al. 2010). Likewise, we have shown that fluorocitrate-mediated activation of astrocytes resulted in 
increased activity of chemosensitive RTN neurons by a purinergic-dependent mechanism (Wenker, 
Kreneisz et al. 2010). In addition, Huckstepp and colleagues showed that hypercapnia opened connexin 
hemichannels on glial fibrillary acidic protein (GFAP)-expressing cells (Huckstepp, Eason et al. 2010), 
thus suggesting that direct CO2 gating of connexin hemichannels results in ATP release from astrocytes. 
We show here that CO2 sensitivity of RTN neurons is fully retained in low Ca
2+–high Mg2+ solution, thus 
further suggesting that that purinergic drive to RTN neurons is not dependent on excitatory synaptic 
transmission.  
In summary, the RTN contains a population of CO2/H
+
-sensitive neurons that sends excitatory 
glutamatergic projections to respiratory centres to stimulate breathing and modulate sympathetic drive to 
the heart and vasculature  (Takakura, Moreira 2011, Moreira, Takakura et al. 2006). In addition to 
activation by CO2/H
+
, RTN neurons are also modulated by various neurotransmitters, including ATP 
(Mulkey, Mistry et al. 2006, Gourine, Kasymov et al. 2010, Wenker, Kreneisz et al. 2010). Based on 
previous and present results, astrocytes (but not neurons) most probably mediate CO2-evoked ATP release 
by a mechanism involving gap junction hemichannels.  
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Chapter 6 Purinergic signaling contributes to chemoreception at the level of the retrotrapezoid 
neucleus but not the nucleus of the solitary tract or medullary raphe. 
 
INTRODUCTION 
Hypercapnic acidosis (i.e., high CO2/H
+
) provides the primary stimulus to breathe. Central respiratory 
chemoreceptors sense changes in tissue CO2/H
+
 and send excitatory drive to respiratory centers to directly 
regulate depth and frequency of breathing (Feldman, Mitchell et al. 2003, Huckstepp, Dale 2011).  The 
process of chemoreception is especially important during sleep and its disruption has been associated with 
central sleep apnea and hypoventilation syndrome (Dempsey, Smith et al. 2012, Guyenet, Mulkey 2010).  
Nevertheless, despite the importance of central chemoreceptors the cellular and molecular mechanism(s) 
underlying this process have yet to be fully elucidated.   
 
Several brain regions are thought to function as important sites of chemoreception including the 
commissural portion of the nucleus of the solitary tract (commNTS) (Dean, Bayliss et al. 1990, Li, Nattie 
2002), medullary raphe (e.g., raphe pallidus, magnus and obscurus) (Hodges, Martino et al. 2004, Nattie, 
Li 2001, Richerson 2004, Wang, Richerson 1999) and retrotrapezoid nucleus (RTN) (Li, Nattie 2002, 
Wang, Shi et al. 2013, Mulkey, Stornetta et al. 2004). Of these, the mechanism(s) of chemotransduction 
are best characterized at the level of the RTN where neurons have been shown to sense changes in 
CO2/H
+
 by two independent but coordinated mechanisms: direct H
+
-mediated activation of pH-sensitive 
neurons by inhibition of a resting K
+
 conductance (Mulkey, Stornetta et al. 2004, Mulkey, Talley et al. 
2007), and indirect activation by purinergic signaling most likely from CO2/H
+
-sensitive astrocytes 
(Gourine, Llaudet et al. 2005, Huckstepp, id Bihi et al. 2010, Mulkey, Mistry et al. 2006, Wenker, 
Kreneisz et al. 2010, Wenker, Sobrinho et al. 2012). Evidence also suggests that purinergic signaling is a 
unique feature of RTN chemotransduction.  For example, it was shown in vivo that CO2/H
+
 facilitates 
ATP release only at discrete locations near the RTN (Gourine, Llaudet et al. 2005) , and RTN astrocytes, 
but not cortical astrocytes respond to H
+
 with increased Ca
2+
-dependent exocytosis of ATP-containing 
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vesicles (Kasymov, Larina et al. 2013).  However, the role of purinergic signaling in putative 
chemoreceptor regions outside the RTN has not been thoroughly investigated.   
 
Indeed, it remains possible that purinergic signaling also regulates neuronal activity in other putative 
chemosensitive regions.  For example, P2-receptors are widely distributed throughout the central nervous 
system including in the NTS and medullary raphe (Yao, Barden et al. 2000). In addition, injections of 
ATP into the commNTS increased breathing (Antunes, Braga et al. 2005), whereas application of a P2-
receptor blocker to the NTS blunted peripheral chemoreflex control of cardiorespiratory function (Paton, 
De Paula et al. 2002).. Furthermore, injection of ATP into the medullary raphe increased breathing (Cao, 
Song 2007), whereas injection of a P2-receptor blocker into the rostral medullary raphe blunted the 
ventilatory response to CO2 of conscious rats (da Silva, Moraes et al. 2012). These results suggest that 
purinergic signaling may contribute to the CO2/H
+
-dependent drive to breathe at other putative 
chemoreceptor regions.  Therefore, the main goal of this study is to determine at the cellular and system 
levels whether purinergic signaling contributes to CO2/H
+
-sensitivity in the commNTS and medullary 
raphe 
 
 To test this possibility, we recorded activity of individual CO2/H
+
-sensitive neurons in putative 
chemosensitive regions in vitro, and phrenic nerve activity (PNA) in vivo during exposure to hypercapnia 
alone and in the presence of P2 receptor blockers.  To determine if cells in the regions of interest 
functionally express P2-receptors, we also tested responsiveness to exogenous application of ATP in vivo 
and in vitro.  In addition, we performed a set of immunohistochemical experiments using the astrocyte 
specific marker aldehyde dehydrogenase (Aldh1L1) to determine the distribution of astrocytes in the 
commNTS, medullary raphe and RTN. We find in vitro that CO2/H
+
-sensitive neurons in the commNTS 
respond to focal ATP application with ~3 fold increase in firing rate, and in vivo unilateral ATP injection 
into this region elicited an increase in PNA by ~81%.  Application of ATP into the medullary raphe had 
no effect on chemoreceptor activity or cardiorespiratory output.  In addition, P2 receptor blockade in the 
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commNTS and medullary raphe had no effect on the ventilatory response to CO2 in vivo, or the firing rate 
response to 15% CO2 in vitro.  Furthermore, we find that astrocytes are underrepresented in the 
commNTS and medullary raphe as compared to the RTN.  In conjunction with previous data that 
purinergic signaling is a critical component of RTN chemoreception, these results indicate that purinergic 
signaling is a unique feature of RTN chemoreception.   
 
METHODS 
In vivo preparation 
 All in vivo experiments conformed to the guidelines approved by the University of São Paulo Animal 
Care and Use Committee. All in vivo experiments were performed in male Wistar rats weighing 250-280 
g. Surgical procedures and experimental protocols were similar to those previously described (Wenker, 
Sobrinho et al. 2012). Briefly, general anesthesia was induced with 5% halothane in 100% O2. A 
tracheostomy was made and the halothane concentration was reduced to 1.4-1.5% until the end of 
surgery. The femoral artery was cannulated (polyethylene tubing, 0.6 mm o.d., 0.3 mm i.d., Scientific 
Commodities, Lake Havasu City, Arizona, USA) for measurement of arterial pressure (AP). The femoral 
vein was cannulated for administration of fluids and drugs. The occipital plate was removed, and a 
micropipette was placed in the medulla oblongata via a dorsal transcerebellar approach for microinjection 
of drugs. A skin incision was made over the lower jaw for placement of a bipolar stimulating electrode, 
next to the mandibular branch of the facial nerve, as previously described (Wenker, Sobrinho et al. 2012).  
The phrenic nerve was accessed by a dorsolateral approach after retraction of the right shoulder blade. To 
prevent any influence of artificial ventilation on phrenic nerve activity (PNA), the vagus nerve was cut 
bilaterally as follows.   
 
Upon completion of the surgical procedures, halothane was replaced by urethane (1.2 g/kg) administered 
slowly i.v. All rats were ventilated with 100% O2 throughout the experiment. Rectal temperature was 
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maintained at 37°C. End-tidal CO2 was monitored throughout each experiment with a capnometer (CWE, 
Inc, Ardmore, PA, USA) that was calibrated twice per experiment with a calibrated CO2/N2 mix. This 
instrument provided a reading of <0.1% CO2 during inspiration in animals breathing 100% O2 and 
provided an asymptotic, nearly horizontal reading during expiration. The adequacy of anesthesia was 
monitored during a 20 min stabilization period by testing for the absence of withdrawal responses, pressor 
responses, and changes in PNA to a firm toe pinch. After these criteria were satisfied, the muscle relaxant 
pancuronium was administered at an initial dose of 1 mg/kg i.v. and the adequacy of the anesthesia was 
thereafter gauged solely by the lack of increase in AP and PNA rate or amplitude to a firm toe pinch. 
Approximately hourly supplements of one-third of the initial dose of urethane were needed to satisfy 
these criteria throughout the recording period (2-3 hours). 
 
In vivo recordings of physiological variables  
As previously described, mean arterial pressure (MAP), phrenic nerve activity (PNA), and end-expiratory 
CO2 (etCO2) were digitized with a micro1401 (Cambridge Electronic Design), stored on a computer, and 
processed off-line with version 6 of Spike 2 software (Cambridge Electronic Design, Cambridge, UK). 
Integrated phrenic nerve activity (iPNA) was obtained after rectification and smoothing (τ = 0.015s) of 
the original signal, which was acquired with a 30-300 Hz bandpass filter. PNA amplitude (PNA amp) and 
PNA frequency (PNA freq) were normalized in each experiment by assigning to each of the two variables 
a value of 100 at saturation of the chemoreflex (high CO2) and a value of 0 to periods of apnea. 
 
Brain slice preparation 
All procedures were performed in accordance with National Institutes of Health and University of 
Connecticut Animal Care and Use Guidelines.  Brainstem slices were prepared as previously described 
(Wenker, Sobrinho et al. 2012). Briefly, neonatal rats (7-12 days postnatal) were decapitated under 
ketamine/xylazine anesthesia and transverse brainstem slices (300 μm) containing the raphe pallidus 
(RPa) were cut using a microslicer (DSK 1500E; Dosaka, Kyoto, Japan) in ice-cold substituted Ringer 
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solution containing (in mM): 260 sucrose, 3 KCl, 5 MgCl2, 1 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, 10 
glucose, and 1 kynurenic acid. Slices were incubated for ~30 min at 37°C and subsequently at room 
temperature in normal Ringer solution (in mM): 130 NaCl, 3 KCl, 2 MgCl2, 2 CaCl2, 1.25 NaH2PO4, 26 
NaHCO3, and 10 glucose. Both substituted and normal Ringer solutions were bubbled with 95% O2-5% 
CO2, extracellular pH (pHo = 7.35).  It should be noted that slices containing the commNTS were 
prepared as described above but with two exceptions: 1) slices were cut in normal Ringer solution (not 
substituted ringers); and 2) slices were incubated at room temperature (not 37°C) for 60 minutes or more.   
 
Slice-patch electrophysiology 
Individual slices were transferred to a recording chamber mounted on a fixed-stage microscope (Zeiss 
Axioskop FS) and perfused continuously (~2 ml min
−1
) with a bath solution of normal Ringer solution 
(same as incubation Ringers above) bubbled with 95% O2-5% CO2 (pHo = 7.35). The pH of the 
bicarbonate-based bath solution was decreased to 6.90 by bubbling with 15% CO2.  All recordings were 
made with an Axopatch 200B patch-clamp amplifier, digitized with a Digidata 1322A A/D converter, and 
recorded using pCLAMP 10.0 software (Molecular Devices). Recordings were obtained at room 
temperature (~22 ºC) with patch electrodes pulled from borosilicate glass capillaries (Warner 
Instruments) on a two-stage puller (P89; Sutter Instrument) to a DC resistance of 4–6 MΩ when filled 
with an internal solution containing the following (in mM): 120 KCH3SO3, 4 NaCl, 1 MgCl2, 0.5 CaCl2, 
10 HEPES, 10 EGTA, 3 Mg-ATP, 0.2% biocytin, and 0.3 GTP-Tris (pH 7.2); electrode tips were coated 
with Sylgard 184 (Dow Corning). All recordings of neuronal firing rate were performed in the cell-
attached configuration to ensure minimal alteration of the intracellular milieu. Firing rate histograms were 
generated by integrating action potential discharge in 10-s bins and plotted using Spike 5.0 software.  
Whole cell voltage clamp recordings (Ihold = -60 mV, in tetrodotoxin to block action potentials) were 
made to verify the serotonergic phenotype of RPa neurons; i.e., medullary raphe neurons are known to 
exhibit a serotonin-activated inward potassium conductance (Bayliss, Li et al. 1997). 
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Drugs 
All drugs were purchased from Sigma unless otherwise indicated. For in vivo experiments, the non-
specific P2-receptor antagonist pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (PPADS) was 
diluted to 100 µM in sterile saline (pH 7.4) or ATP (10 mM) and injected into the RTN using single-
barrel glass pipettes (tip diameter of 25 µm) connected to a pressure injector (Picospritzer III, Parker 
Hannifin Corp, Cleveland, OH).  For each injection we delivered a volume of 50 nl over a period of 5s. 
These glass pipettes also allowed recordings of field potential properties that were used to help direct the 
electrode tip to the desired site. Injections in the RTN region were guided by recordings of the facial field 
potential (Brown, Guyenet 1985), and were placed 250 μm below the lower edge of the field, 1.7 mm 
lateral to the midline, and 200 μm rostral to the caudal end of the field. Recordings were made on one side 
only; the second injection was made 1-2 min later at the same level on the contralateral side. Injections 
into the medullary raphe were placed in the raphe pallidus (N= 6) and the parapyramidal region (N=7). 
Injections in the commNTS region were centered ~400 μm caudal to the calamus scriptorius.  We 
included a 5% dilution of fluorescent latex microbeads (Lumafluor, New City, NY) with all drug 
applications to mark the injection sites and to verify spread of the injections.   
 
For in vitro experiments, we bath applied suramin (100 µM) to block P2-receptors. In addition, ATP (1 
mM in HEPES buffered medium, pH 7.3) was delivered focally using low-resistance pipettes connected 
to a Picospritzer III (Parker Instrumentation, Cleveland, OH).  Application times were 600 ms, and 
vehicle control experiments were performed to ensure agonist responses were not attributable to pressure 
artifacts.  
 
Immunohistochemistry 
Anesthetized rat pups (p7-12) were perfused with 4% paraformaldehyde (PFA) solution through the left 
ventricle. The brain was dissected and fixed overnight at 4°C in 25 ml of 4% PFA. Coronal medullary 
slices (50 µm thick) containing the RTN, NTS, and RPa were obtained with a Leica microslicer. Sections 
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were stored in cryogenic glycol solution at -20°C prior to staining. Fixed slices were rinsed three times in 
PBS and blocked and permeabilized in PBS solution with 5% normal goat serum (NGS) and 0.5% Triton 
X-100. Sections were incubated overnight for two days at 4°C in primary antibodies (mouse anti-
Aldh1L1, 1:1000 dilution) diluted in 5% NGS, 0.5% Triton X-100 and  PBS. Sections were rinsed 3 times 
in PBS and incubated in secondary antibodies (Cy3-conjugated donkey anti-rabbit  IgG, 1:500 dilution; 
Alexa 488-conjugated donkey anti-mouse IgG, 1:1000 dilution) diluted in 5% NGS, 0.5% Triton, and 
PBS for one hour at room temperature. The slices were mounted using Vectashield with DAPI.  
 
Confocal z-stack images were taken of the RTN, commNTS, and raphe pallidus using a Nikon A1R 
confocal microscope with 40x oil immersion objective. Serial z-stacks were taken of both DAPI and alexa 
488 channels, to identify nuclei and astrocyte soma a processes. The z-stacks were processed and 
analyzed in Image J. Astrocytes were counted by identifying nuclei with greater than 50% surrounded by 
Aldh1L1 staining. Volume was determined by measuring the 2-D (x-y plane) area of interest and 
multiplying this area by the slice thickness (z stack depth) of 50 µm. Astrocyte cell counts for each slice 
(N=4 animals) were normalized to volume. 
 
Statistics 
Data are reported as mean ± standard error of the mean. Statistical analysis was performed using Sigma 
Stat version 3.0 software (Jandel Corporation, Point Richmond, CA).  T-test, paired t-test or one-way 
ANOVA followed by the Newman-Keuls multiple comparisons test were performed as appropriate (p < 
0.05). 
RESULTS 
This study is composed of both in vitro and in vivo experiments.  In the brain slice preparation, I 
determine if purinergic signaling can influence basal activity or CO2/H
+
-sensitivity of putative 
chemoreceptors by testing effects of focal ATP application on firing rate and bath application of a P2 
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receptor blocker (suramin or PPADS) on CO2/H
+
-responsiveness of neurons in the commNTS and 
medullary raphe.  To provide a functional basis for these results, my collaborators at the University of Sao 
Paulo tested in vivo the effects of ATP and PPADS on baseline cardiorespiratory activity and CO2-
responsivness.  As a positive control for ATP injections in the commNTS and raphe, my collaborators 
also test effects of focal ATP application into the RTN on breathing and blood pressure.  In addition, 
considering that astrocytes are the most likely source of CO2/H
+
-evoked ATP release in the RTN, we 
performed a set of immunohistochemical experiments using the astrocyte specific marker aldehyde 
dehydrogenase (Aldh1L1) to determine the relative density of astrocytes in the RTN, commNTS and 
medullary raphe.   
 
Purinergic signaling in the commNTS increases activity of chemosensitive neurons and respiratory 
activity but does not contribute to CO2/H
+
-responsiveness. 
We recorded from CO2/H
+
-sensitive commNTS neurons in slices to characterize effects of purinergic 
signaling on baseline activity and CO2/H
+
-responsiveness. As previously described (Conrad, Nichols et al. 
2009), a neuron was designated CO2/H
+
-sensitive if it was spontaneously active under control conditions 
(5% CO2) and responded to 15% CO2 with a ≥ 0.5 Hz increase in firing rate (this corresponds with a 
chemosensitivity index of ~150%). We did not find any CO2-inhibited cells but this is not surprising 
considering that only a small minority of cells in this region have been shown to be inhibited by 
hypercapnia (Dean, Bayliss et al. 1990). The average firing rate of CO2/H
+
-sensitive cells was 0.58 ± 0.14 
Hz (N = 7) under control condition and 2.06 ± 0.46 Hz in 15% CO2 (i.e., CO2 increased activity 1.49 ± 
0.25 Hz, N = 7, Figs. 16A-B).  This level of CO2/H
+
-sensitivity is nearly identical to what has been 
described previously for cells in this region (Conrad, Nichols et al. 2009, Dean, Bayliss et al. 1990) so we 
are confident that we are recording from the group of cells thought to function as chemoreceptors. To gain 
some insight into the neurochemical phenotype of CO2-sensitive commNTS neurons, we filled recorded 
cells with biocytin for subsequent immunohistochemical analysis using antibodies for the transcription 
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factor Phox2b and choline acetyltranferase (ChAT; marker of cholinergic neurons).  We found that 5 of 5 
CO2-sensitive commNTS neurons were negative for Phox2b and ChAT (Figs. 16D-G).    
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Figure 16 
Purinergic signaling modulates activity but not CO2/H
+
-sensitivity of NTS neurons in vitro.  A, 
firing rate trace from a commNTS neuron shows that under control conditions exposure to 15% CO2 
increased neuronal activity of ~1 Hz in a reversible and repeatable manner.  Under control conditions, 
focal application of ATP (1 mM) evoked a rapid and robust increase in firing rate of ~ 3 Hz.  Bath 
application of the P2-receptor blocker suramin (100 µM) had no effect on basal activity but significantly 
attenuated the firing rate response to ATP.  In the continued presence additional bouts of 15% CO2 
increased firing rate by an amout similar to under control conditions.  B, summary data (N=5) shows that 
suramin had no measurable effect on CO2/H
+
-sensitivity of commNTS neurons. C, summary data (N=5) 
confirms that suramin effectively blunted ATP responsiveness of these neurons.  * different from control 
(p < 0.05). D-G, biocytin labeled CO2/H
+
-sensitive commNTS neuron (D, arrow) is immuno-negative for 
choline acetyltranferase (ChAT) (E) and phox2b (F), panel G shows merged images of the same cell in 
D-F.  Each image is the average projection of a confocal stack; around 30 images taken every 0.26 μm in 
the Z plane. Scale bar is 20 µm. 
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To determine if purinergic signaling contributes to activity of commNTS neurons, we first measured the 
firing rate response CO2/H
+
-sensitive neurons in this region to focal application of ATP (1 mM in HEPES  
buffered saline, pH 7.3). Under control conditions all five cells tested exhibited a large reversible and 
repeatable increase in activity (increase of 3.38 ± 1.24 Hz, N = 5) in response to ATP (Figs. 16A,C). Bath 
application of the P2-receptor blocker suramin had no discernible effect on baseline activity (firing rate 
under control conditions and in suramin was 0.58 ± 0.14 and 0.66 ± 0.13 Hz, respectively), suggesting 
these cell do not receive purinergic drive under control conditions. As expected, suramin decreased the 
firing rate response to ATP by 67.0 ± 7.2% (N = 5), thus confirming that P2-recepotrs are effectively 
blocked under these conditions. However, suramin did not blunt the firing rate response to CO2 (firing 
rate under control conditions and in suramin was 1.49 ± 0.25 and 1.58 ± 0.28 Hz, respectively) (Figs. 
16A-B). This indicates that CO2-sensitive commNTS neurons are activated by purinergic signaling; 
however, this signaling mechanism does not contribute to CO2-responsivness of these cells in vitro. 
 
It is possible that endogenous purinergic drive to CO2/H
+
-sensitive commNTS neurons was disrupted in 
our in vitro preparation. Therefore, we also tested effects of commNTS injections of ATP and a P2-
receptor blocker (PPADS) on baseline breathing and the ventilatory response to CO2 in anesthetized rats. 
Consistent with our slice data, we found that injection of ATP (10 mM - 50 nl) into the commNTS 
elicited an increase in phrenic nerve amplitude (PNA ampl) by 46 ± 6% and frequency (PNA freq) by 103 
± 11%. ATP injections into this region also increased MAP (21 ± 4, vs. saline: 3 ± 1 mmHg, p = 0.0032) 
(Figs. 17A-E).  Also consistent with our slice data, bilateral injections of a P2-receptor blocker (PPADS; 
3 mM - 50 nl; N = 6/group) into the commNTS did not change resting PNA (99 ± 7% of control, p = 
0.176) or MAP (124 ± 5 mmHg compared to saline 123 ± 7 mmHg, p = 0.0752) (Fig. 18A). Furthermore, 
bilateral PPADS injections into the commNTS did not affect cardiorespiratory response to CO2; exposure 
to 10% CO2 increased PNA amplitude  (103 ± 9% vs. saline: 99 ± 13%, p = 0.175), PNA frequency (107 
± 6% vs. saline: 105 ± 4%, p = 0.156) and blood pressure (18 ± 7 mmHg vs. saline: 21 ± 4 mmHg, p = 
0.136) (Figs. 18A-E).   
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Figure 17 
Injection of ATP into the commNTS increased breathing and blood pressure in vago-sino-aortic 
denervated rats by a P2-receptor dependent mechanism.  A, recordings of AP and PNA show that 
application of ATP (10 mM, 50 nl) into the commNTS increased breathing and blood pressure when 
preceded by injection of saline into this same region (i.e., control condition) but not after injection of 
PPADS into this region.  Cardiorespiratory responses to ATP partly recovered after washing PPADS for ~ 
1 hr.  B, histology section showing the distribution of fluorescent microbeads within the commNTS.  C-
E, summary data (N=5) show changes in mean arterial pressure (ΔMAP) (C), PND amplitude (ΔPND 
ampl) (D) and PND frequency (ΔPND freq) (E) elicited by injection of saline or ATP into the commNTS. 
Abbreviations: Gr, gracile nucleus; cc, central canal.  Scale bar in B is 100 µm. 
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Figure 18 
P2-receptor blockade at the level of the commNTS had no effect on hypercapnia-induced changes 
in cardiorespiratory activity of anesthetized vago-sino-aortic denervated rats. A, recordings of end-
expiratory CO2 (etCO2), arterial pressure (AP) and integrated phrenic nerve activity (iPNA) show the 
pressure and ventilatory responses of a rat to hypercapnia under control conditions (i.e., after saline 
injection) and 10 min after PPADS (3 mM, 50 nl) was injected into the commNTS.  B, computer-assisted 
plots of the center of the injection sites revealed by the presence of fluorescent microbeads included in the 
injectate (coronal projection on plane Bregma -14.3 mm; (Paxinos, Watson 1982).  C-E, summary data 
(N=6) show that commNTS injections of PPADS had no effect on CO2-induced changes in mean arterial 
pressure (ΔMAP) (C), PND amplitude (ΔPND ampl) (D) and PND frequency (ΔPND freq) (E).  
Abbreviations: Gr, gracile nucleus; py, pyramids; Sp5, spinal trigeminal tract; XII, hypoglossal motor 
nucleus; cc, central canal. Black dots represent the injections sites in the commNTS.   
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For these experiments, injections of ATP or PPADS were centered about 400 μm caudal to the calamus 
scriptorius (Fig. 17B and 18B).  A single injection of ATP or PPADS was administered in or near the 
midline. Based on the distribution of the fluorescent microbeads (Fig. 17B), the injectate spread 
bilaterally ~ 500 μm from the injection center and ~300 μm from the injection center in the rostrocaudal 
direction. 
  
Purinergic signaling in the medullary raphe does not modulate activity of CO2-sensitive neurons in 
vitro or contribute to the chemoreflex in vivo.   
We recorded from CO2/H
+
-sensitive medullary raphe neurons in slices to characterize effects of 
purinergic signaling on baseline activity and CO2-resonsivness. For these experiments we targeted the 
raphe pallidus at approximately the same rostrocaudal level as the RTN (-11.6 mm bregma). Cells in this 
region were considered CO2/H
+
-sensitive (activated or inhibited) if they respond to 15% CO2 with ≥ 20% 
change in firing rate (this corresponds with a chemosensitivity index of ≥ 120% or ≤ 80%).  This criteria 
is similar to previous definitions of raphe chemosensitivity (Richerson, 1995; Wang & Richerson, 1999). 
It should be noted that cells were presumed to be serotonergic based on i) location, ii) CO2/H
+
-sensitivity, 
and iii) expression of a characteristic serotonin-activated inward potassium conductance (Bayliss et al., 
1997) measured in voltage clamp at the end of each experiment, data not shown). The majority of cells in 
this region did not respond to 15% CO2, as expected for raphe neurons in slices isolated from animals ≤ 
12 days of age (Wang & Richerson, 1999). Raphe neurons that were stimulated by hypercapnia (N=6) 
had a spontaneous discharge rate of 0.96 ± 0.26 Hz in 5% CO2 that increased to 1.53 ± 0.33 Hz in 15% 
CO2 (Figs. 19A-B).  Raphe neurons that were inhibited by hypercapnia (N=3) had a spontaneous firing rat 
of 0.70 +/- 0.13 in 5% CO2 that decreased to 0.28 ± 0.06 in 15% CO2 (Figs. 19C-D).    
 
 To determine if purinergic signaling contributes to activity of these cells, we next measured 
CO2/H
+
-responsiveness of raphe pallidus neurons when P2 receptors are blocked with suramin. Bath 
application of suramin (100 µM) had no measurable effect on baseline activity or CO2/H
+
-sensitivity of  
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Figure 19 
Purinergic signaling does not modulate activity or CO2/H+-sensitivity of raphe pallidus neurons in 
vitro.  A, trace of firing rate from a CO2/H+-activated RPa neuron shows that exposure to 15% CO2 
increased firing rate ~0.5 Hz under control conditions and when P2 receptors were blocked with suramin 
(100 µM). In addition, focal application of ATP (1 mM) had no effect on neuronal activity (arrow).  B, 
summary data (N=6) shows that suramin had no effect on the CO2/H
+
-activated RPa neurons.  C, firing 
rate trace from a CO2/H+-inhibited RPa neuron shows that exposure to 15% CO2 decreased firing rate by 
~ 0.3 Hz under control conditions and during P2 receptor blockade with suramin.  Focal application of 
ATP (1 mM) had no effect on neuronal activity (arrow).  D, summary data (N=3) shows that suramin had 
no effect on the CO2/H
+
-inhibited RPa neurons. // designates 10 min time breaks.  
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these cells. For example, in the presence of suramin CO2/H
+
-activated cells respond to hypercapnia with 
an increase in firing rate from 1.12 ± 0.36 Hz to 1.74 ± 0.15 Hz (Figs. 19A-B). This response corresponds 
with an activity increase of 0.60 ± 0.15 Hz which is not significantly different from CO2/H
+
-induced 
increase under control conditions (0.57 ± 0.11 Hz). Similarly, in the presence of suramin CO2/H
+
-
inhibited neurons respond to 15% CO2 with a decrease in firing rate from 0.76 ± 0.12 Hz to 0.39 ± 0.12 
Hz (Figs. 19C-D).  This corresponds with a 0.39 ± 0.12 Hz decrease in activity which is similar to 
CO2/H
+
-mediated inhibition under control conditions (Figs. 19C-D). Furthermore, in a separate series of 
experiments we found that 11 (7 CO2/H
+
-activated and 6 CO2/H
+
-inhibited) of 13 CO2/H
+
-sensitive raphe 
pallidus neurons showed no measurable response to focal application of ATP (1 mM in HEPES buffered 
saline, pH 7.3) (Figs. 19A-C). Two raphe neurons (one CO2-activated and one CO2-inhibited) responded 
to ATP with an increase in firing rate (data not shown).  Together, these results indicate that purinergic 
signaling does not contribute to CO2/H
+
-sensing by raphe pallidus neurons in vitro.   
 
To determine if purinergic signaling in the medullary raphe contributes to the whole animal chemoreflex, 
we tested effects of medullary raphe injections of ATP and PPADS on baseline breathing and the 
ventilatory response to CO2 in urethane-anesthetized rats. For these experiments we targeted the raphe 
pallidus (RPa) (N = 6) and the paraparamidal region (Ppy) (N = 5) because serotonergic cells in region 
reportedly function as chemoreceptors (Richerson 2004) and they are located within diffusion distance 
(estimated to be ~400 µm from the ventral surface (Spyer, Gourine 2009) from sites of CO2/H
+
-evoked 
ATP release on the ventral surface. Injections of PPADS were placed bilaterally in the medullary raphe in 
these rats (Fig. 20B). The injection center was 200-230 µm below the facial motor nucleus, 200 µm 
rostral to the caudal end of this nucleus and 1 mm lateral to the midline as previously demonstrated 
(Mulkey, Stornetta et al. 2004, Takakura, Moreira 2011).  Consistent with our in vitro data, we found that 
bilateral injections of PPADS (3 mM - 50 nl) into either the RPa or Ppy had no effect on baseline PNA or 
the ventilatory response to CO2.  For example, bilateral injections of PPADS (3 mM - 50 nl; N = 8/group) 
into these did not change resting PNA (101 ± 3% of control, p = 0.246) or MAP (119 ± 3 mmHg 
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Figure 20 
P2 receptor antagonist injections into the medullary raphe had no effect on hypercapnia-induced 
changes in arterial pressure and PNA in vago-sino-aortic denervated rats. A, recordings from one rat 
show effects of injection of PPADS into the RPa/Ppy on changes in phrenic nerve activity (PNA) elicited 
by an increase of end-expiratory CO2 from 5 to 10%. Responses were recorded 10 min after injection of 
saline (50 nl) or PPADS (3 mM, 50 nl) into the RPa/Ppy. B, computer-assisted plot shows the center of 
the injection sites (coronal projection on plane Bregma -11.6 mm; (Paxinos, Watson 1982).  C-D, 
summary data (N=8) shows that PPADS injection into the RPa/Ppy had no effect on CO2-induced 
changes in mean arterial pressure (ΔMAP) (C), PND amplitude (ΔPND ampl) (D) or PND frequency 
(ΔPND freq) (E).  Abbreviations: py, pyramid; RPa, raphe pallidus; RPpy, raphe parapyramidal ; Sp5, 
spinal trigeminal tract; VII, facial motor nucleus. Black dots represent the injections sites in the RPa/Ppy.  
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compared to saline 117 ± 4 mmHg, p = 0.234) (Fig. 20A).  In addition, bilateral injections of PPADS into 
these regions did not affect the hypercapnia-induced increase in PNA amplitude (106 ± 11% vs. saline: 
105 ± 14%, p = 0.237), PNA frequency (102 ± 8% vs. saline: 101 ± 5%, p = 0.264), or pressor response 
(22 ± 4 mmHg vs. saline: 22 ± 6 mmHg, p = 0.179) (Fig. 20A-E). Also consistent with our slice data, we 
found that injections of ATP (10 mM - 50 nl) into the medullary raphe had no effect on PNA ampl, PNA 
freq and blood pressure (Figs. 21A-E).    
 
Application of ATP into the RTN increases cardiorespiratory activity 
There is strong evidence that purinergic signaling contributes to RTN chemoreception (Gourine, Llaudet 
et al. 2005, Gourine, Kasymov et al. 2010, Huckstepp, id Bihi et al. 2010, Wenker, Kreneisz et al. 2010, 
Wenker, Sobrinho et al. 2012). We confirm this possibility by testing effects of unilateral injections of 
ATP into the RTN on cardiorespiratory activity. These experiments also serve as a positive control for 
similar experiments in the commNTS and medullary raphe (described above). Consistent with previous 
evidence (Gourine, Llaudet et al. 2005, Mulkey, Mistry et al. 2006), we found that unilateral injection of 
ATP into the RTN increased MAP (14 ± 3, vs. saline: 2 ± 3 mmHg, p = 0.034), PNA amplitude by 26 ± 
5% and PNA frequency by 21 ± 4% (Fig. 22A-E).  These results confirm that purinergic signaling at the 
level of the RTN regulates cardiorespiratory activity.   
 
The RTN contains a higher density of protoplasmic astrocytes compared to the cNTS or RPa.   
Previous evidence suggests that CO2-evoked ATP release from astrocytes contributes to RTN 
chemoreception (Gourine, Kasymov et al. 2010, Huckstepp, id Bihi et al. 2010, Wenker, Kreneisz et al. 
2010, Wenker, Sobrinho et al. 2012). In the present study we show that purinergic signaling does not 
contribute to chemoreception in the commNTS or medullary raphe. We postulate that the differential role 
of purinergic signaling in these regions results from a higher density of astrocytes in the RTN compared 
to the commNTS or medullary raphe. To test this possibility, we determine the relative density of 
astrocytes by counting the number of  
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Figure 21 
Injection of ATP into the medullary raphe had no effect on breathing or blood pressure.  A, 
recordings of AP and PNA show that application of ATP (10 mM, 50 nl) into the medullary raphe 
(RPa/Ppy) did not affect blood pressure or respiratory motor output.  B, histology section showing the 
distribution of fluorescent microbeads within the RPa.  C-E, summary data (N=11) show that RPa/Ppy 
injections of ATP had no effect on mean arterial pressure (ΔMAP) (C), PND amplitude (ΔPND ampl) (D) 
or PND frequency (ΔPND freq) (E).  Scale bar in B is 50 µm. 
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Figure 22 
ATP injections into the RTN increase cardiorespiratory activity. A, recordings of arterial pressure 
(AP) and phrenic nerve activity (PNA) show that under control conditions unilateral injection of ATP (10 
mM, 50 nl) into the RTN increased breathing and blood pressure.  Injection of PPADS (3 mM, 50 nl) into 
the RTN blocked cardiorespiratory responses to subsequent applications of ATP.  B, computer-assisted 
plot and representative histological section show center of injection sites (coronal projection on plane 
Bregma -11.6 mm; (Paxinos, Watson 1982)). C-D, summary data (N=6) show changes in mean arterial 
pressure (ΔMAP) (B), PND amplitude (ΔPND ampl) (C) and PND frequency (ΔPND freq) (D) elicited by 
injection of saline or ATP into the RTN.  Abbreviations: py, pyramid; RPa, raphe pallidus; Sp5, spinal 
trigeminal tract; VII, facial motor nucleus. Black dots represent the injections sites in the RPa/Ppy. Top 
and bottom scale bars in B are 1 mm and 50 µm, respectively. 
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Aldh1L1-positive cells in a 1 mm
2
 section within the regions of interest (see methods for details). 
Astrocytes were counted in confocal Z-stack images by identifying DAPI-labeled nuclei with greater than 
50% surrounded by Aldh1L1 staining. Images of the RTN were taken in a region located between the 
pyramids and trigeminal and directly ventral to the facial motor nucleus at a depth ~100 µm from the 
ventral surface (Fig. 23A). Images of the raphe pallidus were taken midline between the pyramids and 
near the ventral surface (Fig. 23B).  Images of the commNTS were taken medial to the solitary tract in 
slices that were ~200 µm caudal to area postrema (-14.04 mm Bregma) (Fig. 23C). We found that the 
RTN contained approximately 3 times as many astrocytes as the commNTS or raphe pallidus (Fig. 23D). 
DISCUSSION 
There is compelling evidence that CO2/H
+
-evoked ATP release from ventral surface astrocytes 
contributes to respiratory drive by activating chemosensitive RTN neurons (Gourine, Llaudet et al. 2005, 
Wenker, Sobrinho et al. 2012, Huckstepp, id Bihi et al. 2010). Here, we confirm that activation of P2-
receptors in the RTN increases cardiorespiratory activity, and we test at the cellular and systems level 
whether purinergic signaling also modulates activity or CO2/H
+
-sensitivity of neurons in two other 
brainstem regions thought to contribute to central chemoreception (i.e., the commNTS and medullary 
raphe). As expected, application of ATP into the RTN elicited a strong increase in breathing and a mild 
increase in blood pressure by a P2-receptor dependent mechanism, thus further supporting the possibility 
that purinergic signaling in the ventrolateral medulla can modulate activity of respiratory chemoreceptors 
(Gourine, Llaudet et al. 2005, Wenker, Sobrinho et al. 2012, Huckstepp, id Bihi et al. 2010) and blood 
pressure regulating C1 cells (Wenker, Sobrinho et al. 2013).  Similar to previous evidence in the RTN, 
CO2/H
+
-sensitive commNTS neurons also respond to focal ATP application with a robust increase in 
firing rate, and in vivo ATP injection into the commNTS increased breathing.  Conversely, CO2/H
+
-
sensitive medullary raphe neurons did not respond to ATP nor did injection of ATP into this region elicit 
a cardiorespiratory response. Contrary to evidence in the RTN, inhibition of P2-receptors in the  
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Figure 23 
The RTN has a higher density of astrocytes than the commNTS or RPa. A-C, diagram (right) and 
photomicrograph (left) of a transverse medullary slices containing the RTN (A1), RPa (B1) and the 
commNTS (C1). Areas labeled in red represent the regions of interest.  Red boxes identify regions of 
interest where confocal images were taken. A2-C2, projection images of confocal z-stacks of the RTN 
(A2), RPa (B2) and NTS (C2), in which the blue channel represents DAPI staining and the green channel 
Aldh1L1 immunoreactivity.  To be counted, a cell had to have a clearly defined nuclei with bright DAPI 
staining as well as bright Aldh1L1 staining around at least half of the nucleus (arrows in each image).  D, 
summary data (N=4 animals) show the relative astrocyte density in the RTN, RPa and commNTS.  Note 
that the RTN had a significantly higher astrocyte density compared to the commNTS or RPa (one-way 
ANOVA on ranks).  These results support the possibility that astrocytes are an important component of 
RTN chemoreception. 
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commNTS and medullary raphe had no effect on basal activity and CO2/H
+
-sensitivity in vitro, or 
baseline cardiorespiratory activity and CO2-responsivness in vivo. Furthermore, we found that the RTN 
contains a higher density of astrocytes compared to the commNTS and raphe pallidus, suggesting that the 
unique role of purinergic signaling in the RTN is a consequence of astrocyte density. Therefore, previous 
and present results suggest that purinergic signaling is a unique feature of RTN chemoreception.   
The RTN is an important sight of chemoreception and intense effort has been made to identify a unique 
CO2/H
+
-sensing mechanism in this region. Evidence indicates that chemosensitive RTN neurons sense 
and respond to changes in tissue CO2/H
+
 directly (Lazarenko, Milner et al. 2009, Onimaru, Ikeda et al. 
2012, Wang, Shi et al. 2013), possibly by inhibition of a K
+
 conductance (Mulkey, Stornetta et al. 2004, 
Mulkey, Talley et al. 2007), and indirectly by CO2/H
+
-evoked ATP release most likely from astrocytes 
(Gourine, Llaudet et al. 2005, Wenker, Sobrinho et al. 2012, Huckstepp, id Bihi et al. 2010).  The identity 
of the neuronal pH-sensor remains unknown and thus precludes further analysis; however, evidence does 
suggest that a subset of RTN astrocytes are uniquely specialized to release ATP in a CO2/H
+
-dependent 
manner.  For example, CO2/H
+
-evoked ATP release has been shown to occur at discrete regions on the 
ventral surface near the RTN but not in deeper brainstem regions or near the dorsal surface (Gourine, 
Llaudet et al. 2005, Huckstepp, id Bihi et al. 2010). In addition, evidence suggests that a subset of ventral 
surface astrocytes but not cortical astrocytes respond to H
+
 with an increase in intracellular Ca
2+
 and 
vesicular release of ATP (Kasymov, Larina et al. 2013). The results presented here build on the 
possibility that purinergic signaling is a unique component of RTN chemoreception by showing that P2-
recepotr blockade in two putative chemoreceptor regions did not affect CO2-responsivness in vitro or in 
vivo. The differential role of purinergic signaling CO2/H
+
-sensing by cells in these regions may result 
from a higher density of astrocytes in the RTN compared to the commNTS and medullary raphe; however 
it is also possible that RTN astrocytes are unique and functionally specialized to release ATP during 
hypercapnia as previously suggested (Kasymov, Larina et al. 2013).    
 109 
 
The caudal portion of the NTS is thought to contribute to central chemoreception because a subset of 
neurons in this region respond to CO2 with increased firing rate (Conrad, Nichols et al. 2009, Dean, 
Bayliss et al. 1990) and focal acidification of this region has been shown to stimulate breathing in 
anesthetized and unanesthetized animals (Li, Nattie 2002, Coates, Li et al. 1993).  Although the cellular 
and molecular identity of CO2/H
+
-sensors in the commNTS are unknown, it is well established that cells 
in this region, including Phox2b immunoreactive neurons (Stornetta, Moreira et al. 2006), relay peripheral 
chemosensory inputs to other components of the respiratory circuit; thus cells in this area are well 
positioned to regulate cardiorespiratory activity in response to hypercapnia.   
 
Previous evidence suggests that purinergic signaling in the commNTS influences cardiorespiratory 
activity. For example, several types of P2-receptors are expressed in the commNTS (Yao, Barden et al. 
2000) and injection of ATP or related analogs into the commNTS of awake rats mimicked 
cardiorespiratory responses (i.e., bradycardia, hypertension and tachypneia) to peripheral chemoreceptor 
activation (Antunes, Braga et al. 2005, de Paula, Antunes et al. 2004, Paton, De Paula et al. 2002). 
Purinergic signaling also contributes to pulmonary stretch receptor-mediated activation of second-order 
relay neurons in the NTS to control inspiration (Gourine, Dale et al. 2008).  Consistent with the 
possibility that purinergic signaling in the commNTS contributes to cardiorespiratory control, we show 
that ATP injections into this region increased cardiorespiratory activity. We also show that CO2/H
+
-
sensitive commNTS neurons are strongly activated by focal ATP application. It should be noted that the 
neurochemical phenotype of CO2/H
+
-sensitive commNTS neurons remains unknown, since these cells 
were immune-negative for Phox2b and ChAT.  Nevertheless, blocking P2-recepotrs in this region did not 
affect the firing rate response to CO2/H
+
 in vitro, or the ventilatory response to CO2 in vivo. These results 
indicate that purinergic signaling can increase activity of CO2/H
+
-sensitive commNTS neurons and 
stimulate cardiorespiratory activity, but this mechanism does not contribute to CO2-responsivness. It 
remains possible that astrocytes in this region contribute to CO2/H
+
-responsiveness of commNTS 
neurons, albeit by an ATP-independent mechanism.  For example, recent evidence showed that 
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acidification decreased glutamate uptake by NTS astrocytes and facilitated gutamatergic slow excitatory 
potentials that could potentially increase integrated output of the NTS to the rest of the respiratory 
network (Huda, McCrimmon et al. 2013).   
 
Serotonergic medullary raphe neurons can strongly influence breathing (Hodges, Richerson 2010)  and 
are thought to function as respiratory chemoreceptors in part because neurons in this area have been 
shown to be acid sensitive in vitro (Wang, Tiwari et al. 2001, Wang, Pizzonia et al. 1998, Severson, 
Wang et al. 2003, Richerson 1995), focal acidification of this region increased breathing in 
unanesthetized awake (Hodges, Martino et al. 2004) or sleeping (Nattie, Li 2001) animals, and genetic 
deletion (Hodges et al., 2008) or selective inhibition (Ray, Corcoran et al. 2011) of serotonergic neurons 
decreased the ventilatory response to CO2. As previously described (Richerson 1995, Wang, Pizzonia et 
al. 1998)  , we found a subset of medullary raphe neurons in slices from neonatal rat pups that responded 
to 15% CO2 with a modest increase or decrease if firing rate.   
 
There is some evidence that CO2/H
+
-sensitivity of raphe neurons is partially dependent on purinergic 
signaling. For example, a study in anesthetized rats showed that microinjection of ATP into the raphe 
magnus and pallidus decreased or increased respiratory activity, respectively (Cao, Song 2007). In 
addition, injection of PPADS into the medullary raphe blunted the ventilatory response to CO2 of 
conscious rats (da Silva, Moraes et al. 2012). Considering that P2-receptors are ubiquitously expressed in 
the central nervous system including at the level of the medullary raphe, we were surprised to find that 
CO2/H
+
-sensitive neurons (i.e., activated or inhibited) in the raphe pallidus did not respond to focal 
application of ATP in vitro, and injection of ATP into the raphe pallidus or the parapiramidal region had 
no effect on baseline breathing in vivo. In addition, blocking P2-receptors in these medullary raphe 
regions did not perturb CO2-sensitivity in vitro or in vivo. These results suggest that purinergic signaling 
does not influence activity or CO2-sensitivity at these raphe nuclei under our experimental conditions.   
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In summary, purinergic signaling contributes to the mechanism by which RTN neurons sense and respond 
to changes in CO2/H
+
; however, this signaling mechanism does not contribute to CO2/H
+
-sensing in the 
commNTS or medullary raphe.  These results are the first evidence for a unique CO2/H
+
-sensing 
mechanism in the RTN. 
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Chapter 7 Summary of Major Findings 
 
Studies from the late 1990’s and early 2000’s indicated that purinergic signaling in the ventrolateral 
medulla is required for proper chemoreception (Thomas, Ralevic et al. 1999, Thomas, Spyer 2000, 
Gourine, Llaudet et al. 2005). This prompted us to ask the question, what role purinergic signaling plays 
in chemoreception at the cellular level? The results of this thesis support a model in which CO2-evoked 
ATP is released from astrocytes via connexin hemichannels to activate RTN neurons and increase 
respiratory activity. This provides valuable insight into the fundamental mechanisms of central 
chemoreception. This thesis reaches four main conclusions. (1) One mechanism for sensing CO2/H
+
 by 
astrocytes in by inhibition of Kir4.1-Kir5.1-like channels and the sodium bicarbonate cotrasporter. (2) 
Functional purinergic signaling is required for proper chemoreception, both in vivo and in vitro, and CO2, 
not pH per se, is the stimulus. (3) The method for ATP release due to CO2/H
+
 is opening of connexin 
hemichannels. (4) The contribution of purinergic signaling to neuronal CO2/H
+
 sensitivity is restricted to 
the RTN/medullary ventral surface. Below, I will discuss these results with respect to the current 
literature and propose future experiments to more decisively answer the above questions. 
 
Conclusions 
(1) A number of previous reports demonstrate functional Kir4.1 channels in astrocytes of the cortex 
(Higashi, Fujita et al. 2001, Olsen, Higashimori et al. 2006, Tang, Taniguchi et al. 2009). These channels 
are active at negative potentials and contribute to the very negative membrane potential observed in all 
astrocytes. In addition Kir4.1 channels are thought to mediate potassium buffering during high neuronal 
activity (Djukic, Casper et al. 2007, Olsen, Sontheimer 2008). Thus, our observation that Kir4.1-Kir5.1 
channels are expressed in astrocytes is by no means unexpected. However, it is unusual to find such a 
large pH-sensitive conductance in astrocytes. In the hippocampus, more extreme pH solution (compared 
to the present study) resulted in only mild inhibition of resting potassium current (Zhou, Xu et al. 2009). 
On the other hand, RTN astrocytes decreased membrane conductance by 50% on average. This translates 
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to approximately a 10 mV decrease in membrane potential, which is enough to activate voltage gated 
channels, including certain connexins (Saez, Retamal et al. 2005). The physiological consequences of this 
astrocytic sensing mechanism are not known. Difficulties with pharmacology prevented us for 
determining the role of Kir4.1 in chemoreception in vivo. Others have found that congenital KO of Kir5.1 
(necessary for physiological pH sensing by Kir4.1) does not affect the central chemoreflex (Trapp, Tucker 
et al. 2011). However, the animals suffer from metabolic acidosis, which is intimately entwined with 
sensation of blood gases, and thus could offset any slight change to chemosensitivity. To more completely 
answer this question it is likely that conditional genetic ablation of Kir4.1 or Kir5.1 is needed (see future 
directions).  
 
(2) The most logical mechanism for ATP released at the medullary ventral surface to affect respiratory 
output, is for the ATP to activate local respiratory neurons which then relay this information to the proper 
respiratory centers. The alternative, diffusion of ATP to the respiratory CPG, seems unlikely, as the 
distance is great and ATP would likely be broken down by ectonucleotidases in the process. In addition, 
ATP applied to the prebotzinger complex results in a biphasic respiratory response (Lorier, Huxtable et al. 
2007), very dissimilar to the response mediated by the central chemoreflex. It was already known that 
ATP could increase action potential activity in RTN, but it was also shown that blockade of P2 blockers 
had no effect on the pH-sensing of the same neurons (Mulkey, Mistry et al. 2006). In the present study we 
found different results when using bicarbonate buffered external solution and decreased pH by elevating 
CO2 concentration. RTN neuronal CO2/H
+
 sensitivity was reduced by ~25% when P2 receptors were 
blocked. This effect was independent of external calcium, synaptic input, temperature and stimulus 
strength. Independent evidence exists that demontstrates changes in CO2, but not necessarily pH, are 
necessary for ATP release (Huckstepp, Eason et al. 2010, Huckstepp, id Bihi et al. 2010), although they 
did not assay neuronal function. However, other studies have demonstrated ATP release by altering pH 
independent of CO2 (Gourine, Kasymov et al. 2010). In addition, these studies found that in the absence 
of functional P2 receptors neurons near the ventral surface lacked CO2/H
+
 chemosenstivity entirely. The 
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reason for the discrepancies between this and the present study is unclear, but a number of experimental 
differences are likely the culprit. In Gourine et al., the authors use organotypic slices, as opposed to acute 
slices, for whole-cell recordings, as opposed to loose-patch recordings, and use a synthetic Phox2a/b 
promoter driving a reporter to identify RTN neurons, as opposed to identification based on CO2/H
+
-
sensitivity used in this study. The synthetic promoter is not specific for central chemoreceptor RTN 
neurons, with expression being seen in other nearby neurons, including the C1 (Abbott, Stornetta et al. 
2009), which could explain the lackluster neuronal chemosensitivity and difference in P2 receptor 
function. One thing in agreement between all groups (Huckstepp, id Bihi et al. 2010, Gourine, Kasymov 
et al. 2010, Wenker, Sobrinho et al. 2012), is that P2 receptor antagonism in the RTN results in decreased 
in vivo chemosensitivity by ~25-30%. 
 
(3) There is consensus that astrocytes in the RTN release ATP, but the mechanism of release is debated 
(Gourine, Kasymov et al. 2010, Huckstepp, id Bihi et al. 2010). The two competing hypotheses are (a) 
calcium-mediated vesicular release and (b) direct CO2 gating of connexin channels (specifically Cx26) 
allowing flux of ATP. In this thesis we assayed for mechanisms of ATP release by using the RTN 
neuronal response to CO2/H
+
 as a readout for ATP release. We found that using a low calcium, high 
magnesium, solution to block vesicular release had no effect on CO2/H
+
 sensitivity of RTN neurons. 
However, pharmacological blockade of connexin hemichannels has similar effects on chemosensitivity as 
did P2 receptor antagonists. In addition, simultaneous antagonism of connexins and P2 receptors had the 
same effect as either one alone, indicating they are both involved in the same signaling pathway. Once 
again, our data best supports that of Huckstepp et al. (2010), but does not sync well with work by Gourine 
et al (2010). Possible explanation for these discrepancies are the same as described above in conclusion 
(2), and likely the different findings related to purinergic signaling’s mechanism of release, effect on 
neuronal chemosensitivity and molecule sensed (i.e. H
+
 versus CO2) are all related. 
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(4) Initial experiments found ATP released in vivo due to hypercapnia was restricted regionally to ventral 
surface of the medulla (Gourine, Llaudet et al. 2005). In horizontal brain slices, Huckstepp et al. (2010) 
also observed ATP release was restricted somewhat in the lateral direction, but also noted that slices 
dorsal to the first slice did not exhibit any ATP release during hypercapnia. This prompted us to wonder 
whether purinergic signaling is a mechanism of CO2/H
+
 sensing that is specific to RTN neurons. The 
search for specific sensing mechanisms is not new (Guyenet, Stornetta et al. 2008). In line with previous 
studies, we found that purinergic signaling is restricted to RTN neurons. Neither medullary raphe nor 
cNTS chemosensitive neurons rely on P2 receptors for their CO2/H
+
 sensing abilities. For cNTS neurons, 
this is in spite of the fact that they do express functional P2 receptors. Interestingly, we did not detect 
functional P2 receptor expression in Raphe neurons. These data provide evidence that purinergic 
signaling involvement in central chemoreception is restricted to the RTN. 
 
Future studies 
The bulk of the experiments in this thesis rely on pharmacological manipulations. As I was once told, “A 
drug seems to lose its specificity with age.” This is not advice against keeping a drug in storage for an 
extended period of time, but it points out that the specificity of a pharmacological agent tends to lessen as 
we learn more about the agent. Lack of specificity aside, using pharmacology to study astrocytes is 
problematic. Astrocytes are cells just like neurons. They express many of the same channels and 
receptors, use calcium as an intracellular signaling mechanism and can release transmitters to affect other 
glial cells and neurons (Kimelberg 2010). Any attempt to use pharmacology to antagonize a mechanism 
in astrocytes will simultaneous antagonize the same mechanism in neurons, making it impossible to 
dissect which cells are responsible for an action. In the present study we do our best to work around this 
but it is inevitable. Future studies should utilize conditional genetic approaches (e.g. GFAP-cre 
expressing mice, or targeted virus mediated infection) to affect astrocytes selectively. Logical next steps 
would include astrocyte specific knock out of genes that encode for Kir4.1, Kir5.1, Cx26, IP3 receptors 
and astrocyte SNARE proteins. Some of these genetic tools have been very useful in the Cortex (Djukic, 
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Casper et al. 2007, Petravicz, Fiacco et al. 2008, Pascual, Casper et al. 2005). The same can be said for 
neurons. This thesis has provided evidence that RTN neurons express functional P2Y receptors. However, 
the molecular identity (i.e. receptor subtype) has been difficult to determine (results not shown). This may 
be best determined using similar conditional genetic manipulations in neurons. Although no system is 
perfect, tools for relatively specific targeting to RTN neurons exist that could allow for targeted 
antagonism of specific P2Y receptor subtypes. Let us also not forget that ~75% of RTN neuronal 
chemosensitivity appears to be intrinsic, with evidence of a background pH-sensitive potassium channel. 
Identification of this channel(s) and its sensing mechanism are necessary for complete understanding of 
RTN chemoreception. Once these precise mechanisms can be targeted efficiently we may be able know 
the exact mechanism of central chemoreception in a behaving animal.  
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